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ABSTRACT 
Aims 
The main objectives for this thesis were: 
 To undertake a systematic review to assess the effectiveness of using care bundles in 
low and lower-middle income countries (LMIC)  
 To complete a modified Delphi study to gain consensus on the most important and 
feasible items to be included in a low-income maternal sepsis bundle  
 To develop an exploratory theory of change (TOC) model to assist in planning the 
implementation of the bundle. 
 
Methods 
To achieve the above aims, a number of research methodologies were used including: 
systematic review & meta-analysis, modified Delphi and undertaking in-country workshops 
to develop a TOC. 
 
Results 
A comprehensive literature search identified 2770 citations, 10 of which were included in 
the systematic review. Meta-analysis showed the use of bundles significantly reduces the 
incidence of infection. Consensus was achieved after three iterations of the modified Delphi, 
with the following final bundle item: Fluids, Antibiotics, Source Control, Transport and 
Monitoring (FAST-M). Multiple workshops were used to build a TOC diagram. 
Conclusion 
A low-income maternal sepsis bundle has been produced through international consensus. 
Framework for an exploratory TOC model has been developed to assist in planning the 
bundle’s implementation. These findings can be used to design an appropriate feasibility 
study to pilot the bundle. 
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INTRODUCTION  
 
Background 
 
 
Maternal sepsis has recently been defined by The World Health Organization (WHO) as, “a 
life-threatening condition - defined as organ dysfunction resulting from infection during 
pregnancy, childbirth, post-abortion, or postpartum period”1. It is a recognised major cause 
of maternal mortality, accounting for over 10% of maternal deaths worldwide2. Although 
this is a complication seen regularly in high-income countries, there are significantly more 
cases of maternal sepsis identified in low and lower-middle income countries3. A recent 
review in 2014 by the WHO identified that the majority of these deaths occur in Sub-Saharan 
Africa, accounting for at least 50% of the total deaths from maternal sepsis globally2. 
 
Other leading causes of maternal mortality globally include postpartum haemorrhage and 
hypertensive disorders2. As part of the United Nation’s Sustainable Development Goals, the 
priority has been to work on reducing maternal deaths4, and research has primarily been 
focussed on the above two conditions. However, sepsis is being recognised as a serious and 
important cause of maternal mortality that requires more attention. It is for this reason that, 
in 2016, the WHO and Jhpiego developed a taskforce called the “Global Maternal and 
Neonatal Sepsis Initiative”1. This collective group of experts’ objective is to promote research 
and development in the field of maternal and neonatal sepsis, aiming to reduce maternal 
mortality from sepsis world wide1. Their work includes the development of the robust, 
evidence-based definition for maternal sepsis, which will help healthcare workers in 
identifying and therefore treating sepsis earlier. 
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The definition of sepsis in general has also been changed recently, following an international 
consensus by leading world experts in sepsis in 2016. The aim was to identify an up-to-date 
definition for sepsis and its classification5. Twenty five years earlier, the first definitions of 
sepsis were developed by an international group of experts, in 1991. At this time, sepsis was 
identified as the “host’s systemic response to infection, in the presence of systemic 
inflammatory response syndrome (SIRS) criteria”6. SIRS criteria included two or more of the 
following: 
 Heart rate >90/bpm 
 Respiratory rate >20/bpm 
 Temperature >38 °C or <36 °C 
 White blood cell count of >12,000/m3 or <4,000/m3 or >10% immature forms6 
 
Severe sepsis was classified as the presence of sepsis with signs of tissue hypo-perfusion, 
and septic shock referred to refractory hypotension in the presence of an infection, despite 
adequate fluid resuscitation6. 
 
A decade later, a new taskforce updated the definition but did not alter it significantly7. 
Twenty-five years after the first definition, experts recognised the changes and advances in 
sepsis research and the same taskforce came together and published “The Third 
International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)5. The findings from 
the taskforce advise the new definition of sepsis to be as follows, “life-threatening organ 
dysfunction caused by a dysregulated host response to infection”5. 
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The clinical criteria have also been updated, to replace “SIRS” with the “SOFA” score 
(sequential [sepsis related] organ failure assessment). This tool works on a points based 
system includes variables such as consciousness level, urine output and blood test results 
include platelet count and creatinine level, among others. A higher SOFA score indicates 
higher mortality with a score of 2 or more indicating an in-hospital mortality chance of more 
than 10%5. 
 
A bedside clinical score called q-SOFA (quick-SOFA) has also been developed using three 
variables only. Patients are likely to have worse outcomes if they have two of the following: 
a respiratory rate of >22/min, altered mentation and a systolic blood pressure of 
<100mmHg5. 
 
The signs of maternal sepsis can be different to that of a non-pregnant patient and often 
patients can deteriorate rapidly8, therefore it is important for clinicians to be aware of the 
signs of sepsis, and to have a robust method of initially managing maternal sepsis to improve 
treatment and reduce mortality rates. This can be further achieved by the use of a sepsis 
care bundle. The confidential enquiry into maternal deaths (MBRRACE-UK) report in 2014 
centred on maternal sepsis, and advised that a sepsis care bundle should be used 
immediately in the management of a woman presenting with sepsis in pregnancy or the 
puerperium9.  
 
A bundle can be identified as, “a collective group of evidence based interventions that, when 
given together, improve overall patient outcomes10”. There should be an all-or-nothing 
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approach to using a bundle, such that all eligible patients should be managed in the same 
way to ensure a standardised approach and to receive the most benefit11.  
 
Various bundles have been created specifically for use in the management of sepsis. The UK 
Sepsis Trust developed the “Sepsis Six” care bundle, which radically changed sepsis 
management for healthcare professionals in the UK12. This easy-to-follow bundle comprised 
of six elements to be carried out within one hour of the suspicion of sepsis, known as “the 
Golden Hour”13. They include the following interventions: 
 Administer Oxygen 
 Take blood cultures 
 Give IV antibiotics 
 Give IV fluids 
 Check serial lactates 
 Measure urine output13 
 
It was found that implementing the elements of this bundle in a timely and efficient manner 
helped to significantly reduce mortality from sepsis in a prospective observational study 
conducted in the UK13. There are also global guidelines including the “Surviving Sepsis 
Campaign”, which offer both three and six hour bundles, intended to be used in the initial 
resuscitation and on-going management of sepsis14. These bundles include more complex 
interventions such as administration of vasopressors (if required) and are generally advised 
to be used in units where critical care facilities are available. None of the above sepsis care 
bundles have been developed with a low income setting in mind and contain measures that 
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are unavailable in a majority of health care settings in low and lower-middle income 
countries15.  
 
In low income countries, clinicians have been unable to implement the elements of these 
kinds of sepsis bundle in the initial management of their patients presenting with sepsis16. 
Specialists in low income countries see it as unsuitable, given the often limited resources 
available17. It is important to ensure mothers living in low and lower-middle income 
countries will have access to essential care when presenting with signs of sepsis. This can be 
achieved by creating a care bundle specific to the needs of low and lower-middle income 
countries. A specialised care bundle for the management of maternal sepsis will provide an 
evidence-based framework that can be used to commence treatment promptly and safely. 
This project will address this important global need and help to combat and reduce maternal 
mortality and morbidity secondary to sepsis. 
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OBJECTIVES 
 
 
The objective of this thesis is to develop a new care bundle, which can be used in the initial 
management of maternal sepsis, in low and lower-middle income countries. 
 
There are three main chapters in this thesis, outlining the work undertaken to develop this 
low-income maternal sepsis bundle. These are summarised below:  
 Chapter 2: Systematic review & meta-analysis on the efficacy of the use of general 
care bundles in low and lower-middle income countries 
 Chapter 3: Development of the low-income maternal sepsis bundle using a robust, 
iterative, international Delphi consensus method 
 Chapter 4: Development of an exploratory theory of change framework to implement 
and operationalise the newly created bundle, produced through in-country meetings, 
which took place in Malawi in May 2016  
 
The longer-term goal, which is outside the remit of this thesis, would be to initially pilot and 
then formally evaluate, through a clinical trial, the care bundle in a low-income country such 
as Malawi. 
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CHAPTER 2: THE USE OF A CARE BUNDLE IN LOW AND LOWER-
MIDDLE INCOME COUNTRIES: A SYSTEMATIC REVIEW AND META 
ANALYSIS  
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ABSTRACT 
 
 
Objective:  
To review the effectiveness of care bundles in comparison to usual care, in low and lower-
middle income countries (LMIC). 
 
Design:  
Systematic Review with Meta-Analysis 
 
Data Sources:  
Medline, Embase, British Nursing Index, Cochrane Library, Cumulative Index to Nursing and 
Allied Health Literature, BioMed Central, PsycINFO, African Index Medicus, Web of Science 
and Science Citation Index (from database inception to December 2015) without language 
restrictions. 
 
Review Methods:  
We performed a systematic review of studies that included adult patients in LMIC and 
compared the use of bundled care to usual care. We selected randomised and non-
randomised studies with a variety of clinically important outcomes. The primary outcome 
included improved care with the use of a bundle. Additional outcomes included incidence of 
infection & mortality outcomes. Two independent reviewers undertook data extraction and 
assessed the quality of the included studies. The Cochrane Risk of Bias tool for randomised 
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and non-randomised studies was used respectively. Data was presented as forest plots with 
and without summary measures. 
 
Results:  
We identified one randomised controlled trial (n=109) and nine before-and-after studies 
(n=87, 055). All studies were set in LMIC and investigated the use of a variety of different 
bundles, including those for sepsis, ventilator-associated pneumonia and catheter-
associated urinary tract infections (UTI) compared to usual or standard care. Meta-analysis 
of five studies showed an overall significant reduction in the incidence of infection with 
bundled care (rate ratio 0.58, 95% confidence interval 0.48 to 0.70, p<0.001). Trends in 
mortality and severity score were also looked at for 3 studies, however these were not 
meta-anlaysed. 
 
Conclusions: 
The use of a care bundle in LMIC can significantly reduce the incidence of infections. These 
results may be used to consider developing care bundles for specific use in low resource 
settings. 
 
Keywords:  developing countries, low income countries, resource-limited, bundle, patient 
care bundle, multi-dimensional approach, early goal directed therapy, care package 
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INTRODUCTION 
A care bundle is defined as a small, straightforward set of evidence-based practices or 
interventions that, when performed collectively and reliably, improve patient outcomes10. 
The Institute for Healthcare Improvement (IHI)10 first developed the concept of using a 
“bundle” initially in a critical care setting back in 200518. A care bundle can be used in a 
variety of situations and has been adapted to cater for many different medical conditions in 
a number of specialties13,19. 
 
The idea of a bundle is to ensure well established best practices are completed for every 
patient, every time10. This allows consistently high quality care and improves the reliability of 
the treatment being offered18. There is also an “all-or-nothing” element to using a care 
bundle, with delivery of the complete bundle and adherence to each component being an 
important factor to a bundle’s success. 
 
Bundles have been used consistently in high-income countries for the past decade with 
encouraging results12,14,20. An important example is the introduction of bundled care in the 
management of sepsis, which has reduced mortality from sepsis21. The Surviving Sepsis 
Campaign has produced evidence-based guidelines on the management of sepsis22, 
culminating in the formation of two bundles: the 6 hour “resuscitation bundle” and the 24 
hour “management bundle”22. Between 2005 and 2008, these bundles were implemented 
voluntarily in 165 sites worldwide, with results being obtained for over 15, 000 patients 
across Europe, South America and the United States. Results showed an overall reduction in 
unadjusted hospital mortality from 37.0% to 30.8% by 2 years with the use of the SSC 
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bundles (p<0.001) and the adjusted odds ratio for mortality also improved the longer a site 
used the bundles (0.8% per quarter and 5.4% over 2 years [95% confidence interval, 2.5-
8.4])22. 
 
The use of care bundles has been shown to be effective in improving clinical outcomes in a 
variety of settings. For instance, Sacks et al showed that the use of a specialised central line 
care bundle can reduce the incidence of central-line associated bloodstream infections 
(CLABSIs) in an adult surgical intensive care unit in the United States. With the use of a 
central line care bundle, the number of CLABSIs reduced from 5.02 to 1.60 per 1,000 
catheter days (rate ratio 0.32, P <0.05)23. This is just one example of the many successfully 
implemented care bundles being used currently in high-income countries. Unfortunately, in 
low and lower-middle income countries (LMIC), the implementation of such bundles can be 
seen as a challenge. 
 
Moreover, further sepsis bundles have been introduced such as “The Sepsis Six” developed 
in the United Kingdom. This six piece evidence-based bundle aims to facilitate sepsis care 
within one hour of patients presenting with sepsis13. Daniels et al13 carried out a prospective 
observational study to compare the delivery of the SSC “resuscitation bundle” in patients 
managed using “The Sepsis Six” toolkit to those managed without it. They found that there 
was a decrease in hospital mortality for patients receiving the sepsis six bundle, with a 
mortality of 20.0% compared to 44.1% of patients who did not receive it (p<0.001)13. The 
authors also stated that patients who received the sepsis six bundle were 14.6 times more 
likely to receive the full SSC resuscitation bundle, suggesting the use of sepsis six 
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“operationally facilitated” the delivery of the SSC bundle13. 
 
In low and lower-middle income countries, delivering all aspects of a care bundle can be 
difficult for a number of reasons, including a lack of resource availability and difficulty in 
accessing diagnostic facilities24. Baelani et al undertook a study looking at the self-reported 
availability of resources necessary to implement the SSC guidelines, in 44 respondents from 
high income countries (such as the United Kingdom and Australia) and 263 respondents from 
African countries, split into sub-Saharan Africa (encompassing mostly low-income countries) 
and Mauritius, North Africa and South Africa (countries rated as middle-income countries 
according to the World Bank). This study found that most resources, including drugs and 
equipment, were reported as less frequently available by respondents in African countries, 
compared to high-income countries, especially those in sub-Saharan Africa. Only 1.4% and 
1.5% of respondents from sub-Saharan Africa and other African countries [Mauritius, North 
Africa and South Africa] respectively, were likely to have the resources to implement the SSC 
guidelines consistentely25. 
 
Results such as these suggest that low and lower-middle income countries may have more 
difficulty in implementing care bundles for a variety of reasons. However, given the 
improvement in care and survival seen with the use of bundles in high-income countries, it is 
interesting to see if similar results can be achieved when bundles are used in lower-income 
countries. The aim of this systematic review and meta-analysis is to investigate the 
effectiveness of using a bundle in improving overall care, in low and lower-middle income 
countries.  
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METHODS 
Data sources and searches 
 
Databases were searched for relevant literature on the use of care bundles in low and lower-
middle income countries (as defined by the World Bank26). The studies selected included 
adult only patients and the use of a care bundle or package, which was defined as: “a small 
set of key evidence-based practices, that are designed to be completed together, aiming to 
improve outcomes more than when the components are implemented individually10”. The 
above definition of a bundle, from the Institute of Healthcare Improvement, was used 
against all studies from the literature search to ensure standardisation of the studies 
selected.  
 
Medline, Embase, British Nursing Index, Cochrane Library, Cumulative Index to Nursing and 
Allied Health Literature, BioMed Central, PsycINFO, African Index Medicus, Web of Science 
and Science Citation Index were searched (from database inception to December 2015). 
Hand searching and checking of reference lists complemented electronic searches. No 
language restrictions were applied to the search. Search terms were "developing countries”, 
“low income countries” “middle-income countries”, “resource-poor”, “resource-limited” 
along with various MeSH terms for low and lower-middle income countries or regions. This 
was accompanied by the terms “bundle”, "patient care bundles", “multi-dimensional 
approach”, “early goal directed therapy”, “quality improvement programme” and "care 
package". The full search strategy used for the Medline search is available in appendix 1. 
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Study selection and data extraction 
 
Both randomised controlled trials and non-randomised studies were selected. The electronic 
searches were firstly scrutinised and the full manuscripts of the selected articles were then 
acquired. Two reviewers (FT and CB) examined the articles and assessed the eligibility of the 
studies for inclusion. No studies were excluded on the basis of quality. Both reviewers (FT 
and CB) extracted information from each article including study characteristics, outcome 
data and quality independently. The primary outcomes included improvement in care and 
reduction in incidence of infection. Several clinically important secondary outcomes were 
also extracted including mortality, bundle compliance and a number of process outcomes 
pertaining to the type of bundle used. 
 
Methodological quality assessment 
Once studies were deemed as suitable for inclusion, the quality was assessed by two 
reviewers (FT and CB). The studies were assessed with tools suitable for the study design. 
We assessed the randomised controlled trial for adequacy of reporting using the CONSORT 
checklist27. The Cochrane Tool for risk of bias in randomised controlled trials28 was then 
used, assessing for selection bias, performance bias, detection bias, attrition bias, reporting 
bias and other sources of bias. Each category could be classified as low, high or unclear risk28 
(table 1). 
 
The remaining papers were non-randomised studies consisting mainly of before and after 
interventional studies. For these papers, we used the TREND statement checklist29 in 
addition to the ROBINS-I tool by the Cochrane group for the evaluation for the risk of bias in 
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non-randomised controlled trials30. This tool evaluated for confounding bias, selection bias, 
intervention bias, missing data, measurement of outcomes and selective reporting bias. For 
each category, it could be classified as low, moderate, serious or critical risk. In order for a 
paper to be judged as overall low risk, each sub-category is required to be low risk. If there 
were any categories characterised as moderate risk, the overall risk would be moderate. If 
one of the categories was given a serious or critical risk outcome, the overall risk would need 
to be adjusted to reflect this, even if some of the sub-categories were characterised as low 
risk. Table 2 shows the results of the quality assessment for the nine included studies. 
 
Statistical Analysis 
We used the random effects model to pool effect estimates in order to account for the 
variability in the setting and type of bundle included within the studies. The other popular 
model used in meta-analysis is the fixed effects model. This is useful in the absence of 
heterogeneity between the studies. By using the random effects model, it is possible to 
account for the likely differences in the variety of studies which share common factors but 
typically differ in ways that will impact the overall result31. 
 
Heterogeneity of treatment effects was evaluated using forest plots and the chi squared 
test, determining the magnitude by computing the I2 tests. Meta-analysis and forest plots 
were created using Review Manager 5.3 and STATA 14th Edition statistical software. 
 
 
Table 1: Quality assessment of Andrews 201432 using the Cochrane ROB Tool 
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Domain Review Author’s Judgment 
Selection Bias 
Random sequence generation LOW RISK 
Allocation concealment LOW RISK 
Performance Bias 
Blinding of participants and personnel UNCLEAR 
Detection Bias 
Blinding of outcome assessment UNCLEAR 
Attrition Bias 
Incomplete outcome data LOW RISK 
Reporting Bias 
Selective Reporting LOW RISK 
Other Bias 
Other source of bias LOW RISK 
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Table 2: Quality assessment of nine non-randomised studies using the Cochrane ROBINS-I tool 
Domain 
 
Study 
 
 
Bias due to 
confounding 
 
Bias in 
selection of 
participants 
Bias in 
classification 
of 
interventions 
Bias due to 
departure 
from intended 
interventions 
Bias due to 
missing 
data 
Bias in 
measurement 
of outcomes 
Bias in 
selection of 
reported 
results 
Overall RoB 
Judgement 
Warren 
201033 
Moderate Low Low Low No 
Information 
Moderate Low Moderate 
Alsadat 
201234  
Serious No 
Information 
Moderate Moderate No 
Information 
Moderate No 
Information 
Serious 
Jacob 
201335 
Moderate Low Low Moderate Low Moderate Low Moderate 
Jaggi 
201236 
Serious No 
Information 
No 
Information 
No 
Information 
No 
Information 
No 
Information 
Critical Critical 
Jaggi 
201337 
Moderate Low Low Moderate Low Low Moderate Moderate 
Mehta 
201338 
Moderate Low Low Moderate No 
Information 
Moderate Moderate Moderate 
Navoa-Ng 
201339 
Moderate Low Low Low No 
Information 
Moderate Low Moderate 
Mohamed 
201440 
Moderate Low Low Low Low Moderate Low Moderate 
Mukhtar 
201441 
Moderate Low Low Low No 
Information 
Moderate Low Moderate 
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RESULTS 
Results of literature search 
Ten studies were included overall, incorporating one randomised controlled trial and nine 
non-randomised before and after studies, with a total of 87, 164 patients. Figure 1 shows the 
process of literature search and selection. The characteristics of the ten included studies 
including study design and setting (country), population, comparators, the types of bundle 
and inclusion and exclusion criteria are presented in table 3.  
 
All ten studies were set in low and lower-middle income countries; India (3 studies), Egypt (2 
studies), The Philippines, Syria, Zambia, Uganda and Kenya. All studies looked at the use of a 
particular type of bundle compared to usual care in adult patients. Bundles included those 
for ventilator-associated pneumonia (VAP: 4 studies34,38,40,41), sepsis (2 studies32,35), catheter-
associated urinary tract infection (CAUTI: 2 studies36,39), central line-associated bloodstream 
infections (CLABSI: 1 study) and finally a postnatal care package (1 study).  
 
Table 4 shows the outcomes of the four VAP studies and the outcome findings for the two 
sepsis studies can be found in table 5. Table 6 shows the important outcomes of the two 
catheter care bundle studies and finally table 7 outlines the results of the remainder of the 
studies (postnatal care package and central line bundle). 
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Figure 1: Flowchart of Study Selection 
 
Total number of citations identified using 
electronic searches on the use of any care 
bundle in low and lower-middle income 
countries (n=2770) 
Exclusions on screening titles and 
abstracts (n=2642) 
Full manuscripts obtained for in-depth 
review (n=128) 
 Electronic searches (n=123) 
 Reference and hand-searching (n=5) 
 
Citations removed after review of full 
manuscripts obtained (n=118) 
 Does not meet requirement for bundle 
definition: 28 
 Removal of duplicates: 34 
 No comparator identified: 3 
 Literature review/not a study: 34 
 Not set in a low or lower-middle income 
country: 4 
 No response from authors regarding 
further information: 10 
 Not able to obtain full manuscript: 4 
 Not adult patients: 1 
 
Final articles fulfilling inclusion criteria for 
systematic review (n=10) 
 Randomised controlled trial (n=1) 
 Non-randomised controlled trial - before and 
after trials (n=9) 
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Table 3: Characteristics of studies in review 
Study, Year 
(Country) 
 
Study Design 
 
Population 
 
Comparator Bundle/ 
Package 
Inclusion Criteria Exclusion Criteria 
Warren, 
201033 
 
(Kenya) 
Pre-test, post-
interventional 
cross-sectional 
design 
Patients having 
postnatal 
consultations from 
September 2006 to 
July 2007 
(n=163)  
 
Patients seeking 
postnatal care 
pre-intervention 
(n=86) 
Kenya post-
natal care 
package 
Women seeking post-
natal care. No formal 
criteria documented 
No specific 
exclusion criteria 
Alsadat, 
201234  
 
(Syria) 
Before and after 
observational 
design 
Patients admitted 
to ICUs in 4 
teaching hospitals 
(n=unavailable) 
Pre-intervention 
period (no 
documentation 
regarding 
controls 
therefore 
n=unavailable) 
VAP Bundle Mechanically 
ventilated for more 
than 24h (defined as 
any 24h period where 
the patient required 
any mode of 
controlled or assisted 
ventilation) and was > 
14 years in age 
 
Patients having 
intermittent 
application of 
continuous 
positive airway 
pressure for 
atelectasis 
prophylaxis 
Jacob, 
201335 
 
(Uganda) 
 
Before and after 
interventional 
study 
Severely septic 
patients triaged in 
the Medical 
Casualty Units in 2 
hospitals from May 
Observation 
cohort from 
separate 
observational 
study carried 
Early 
monitored 
sepsis 
management 
bundle 
Adults (age ≥ 18 
years) with suspected 
infection; has two of 
the following: a) 
axillary temperature 
Suspected surgical 
or obstetric 
emergency; shock 
without suspected 
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2008 to May 2009  
(n=426) 
 
out July to 
November 2006 
(n=245) 
>37.5°C or <35.5°C, b) 
heart rate >90 
beats/min, c) 
respiratory rate >20 
breaths/min; systolic 
blood pressure (SBP) 
≤ 100 mmHg; lactate 
concentration >2.5 
mmol/L or Karnofsky 
Performance Scale 
(KPS) score ≤40 
 
infection  
 
Jaggi, 201236 
 
(India) 
Before and after 
study  
 
 
 
 
Adult patients in 
both ITU and wards 
with CAUTI from 
July to December 
2009 
(n=unavailable) 
Pre-intervention 
patients 
observed from 
January to June 
2009 (historical 
controls – n= 
unavailable) 
 
Catheter 
Care Bundle 
Not formally 
documented 
Not formally 
documented 
Jaggi, 201337 
 
(India) 
 
Before and after 
cohort study 
All adult patients in 
ITU from December 
2004 to February 
2012 (n=31903) 
 
Pre-intervention 
patients from 
September 2004 
to November 
2004 (n=3747) 
 
Central Line 
Care Bundle 
Diagnosis of CLABSI 
consistent with 
criteria 
No specific 
exclusion criteria 
Mehta, 
201338 
Quasi-
experimental 
All adult patients in 
ITU from 
Pre-intervention 
patients from 
VAP  Bundle 
and Infection 
Diagnosis of VAP 
consistent with 
No specific 
exclusion criteria 
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(India) 
prospective 
cohort study 
September 2004 to 
October 2011 
(n=42966) 
July 2004 to 
September 2004 
(n=3979) 
 
Control 
Approach 
criteria 
Navoa-Ng, 
201339 
 
(The 
Philippines) 
Before and after 
observational 
surveillance 
study 
All adult patients in 
ITU during 
February 2006 to 
December 2010 
(n=2898) 
Pre-intervention 
patients from 
December 2005 
to February 
2006 (n=283) 
 
Catheter 
Care  Bundle 
and Infection 
Control 
Approach 
Diagnosis of CAUTI 
consistent with 
criteria 
No specific 
exclusion criteria 
Andrews, 
201432  
 
(Zambia) 
Single-centre 
non blinded 
randomised 
controlled trial 
(RCT) 
All patients 
presented to the 
Emergency 
Department from 
February to July 
2012 (n=49) 
 
Usual care 
group, 
randomised 
(n=54) 
Simplified 
Severe Sepsis 
Protocol 
(SSSP) 
18 years old or older, 
met criteria for severe 
sepsis upon 
presentation to the 
emergency 
department or 
manifested severe 
sepsis within 24 hours 
Gastro-intestinal 
bleed, required 
immediate surgery, 
suspected 
congestive heart 
failure 
exacerbation end-
stage renal 
disease, raised 
jugular venous 
pressure (JVP) 
more than 3 cm 
 
Mohamed, 
201440 
 
(Egypt) 
Before and after 
interventional 
study 
Adult medical and 
surgical patients in 
ICU from 
September 2012 to 
August 2013 (n=98) 
Pre-intervention 
patients from 
September 2011 
to August 2012 
(n=105) 
VAP Bundle Over 18 years old, 
mechanically 
ventilated in ITU for 
>48 hours 
Intermittent 
application of 
CPAP for 
atelectasis 
prevention, 
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patients 
transferred to 
another hospital, 
death within 48 
hours of 
admission, those 
diagnosed with 
either PE or GI 
bleed 
 
Mukhtar, 
201441 
 
(Egypt) 
Before and after 
observational 
design 
Adult medical and 
surgical patients 
within the ICU form 
September 2011 to 
June 2012 (n=77) 
 
Pre-intervention 
patients from 
March 2011 to 
September 2011 
(n=48) 
VAP Bundle Over 18 years old, 
hospitalised in the ICU 
due to trauma, 
mechanically 
ventilated for at least 
48 hours, and met the 
diagnostic criteria for 
VAP 
No specific 
exclusion criteria 
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Table 4: Outcomes from VAP bundle studies in review 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study,  
Year 
 
Incidence of VAP           
VAP rate = n per 
1000 ventilator 
days 
 
Length of Stay in ITU Severity Score 
(APACHE II)  
Mean Score (+/-SD) 
Mortality Rate 
n/N (%) 
 
Duration of ventilation 
Alsadat, 
201234  
Before: 30, 24, 12 
After: 6.4, 19, 4.9 
 
- 
 
- - - 
Mehta, 
201338 
Before: 17.43 
After: 10.81 
RR 0.62 (95% CI 
0.5-.78) p=0.0001 
- - - Mean number of days (+/-
SD) 
Before: 1.21 (+/-3.1) 
After: 1.42 (+/- 5.17) 
p=0.0001 
 
Mohamed, 
201440 
 
 
 
 
Before: 26 
After: 11 
Mean number of days 
(+/-SD) 
Before: 15.4 (+/- 5.2) 
After: 10.8 (+/- 4.9) 
p=0.036 
Before: 21.4 (+/-4.2) 
After: 20.6 (+/-5.1) 
p=0.1 
 
Before: 24/105 
(22.9) 
After: 15/98 (15.3) 
p=0.04 
Mean number of days (+/-
SD) 
Before: 12.8 (+/-4.9) 
After: 8.5 (+/- 4.3) 
p=0.038 
Mukhtar, 
201441 
 
Before: 42 
After: 19 
p=0.001  
Median number of days 
(range) 
Before: 13 (4-78) 
After: 7 (4-44) 
p=0.015 
Before: 20 (+/- 7) 
After: 21 (+/-8) 
p=0.7 
 
Before: 31/48 
(64.6) 
After: 50/77 (64.9) 
p=0.9 
Median number of days 
(range) 
Before: 8 (3-49) 
After: 6 (3-28) 
p=0.03 
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Table 5: Outcomes from sepsis bundle studies in review 
Study,  
Year 
 
Severity Score 
(APACHE II)  
 
Mortality Rate 
 
 
Adverse/morbidity outcomes Process outcomes 
Jacob, 
201335  
- Before: 45.7 % 
After: 33.0% 
p=0.005  
Adverse fluid reactions n/N (%) 
 
Before: Nil 
After: 56/426 (13.1) 
Volume of IV fluids given in first 6 hours - median no. 
L (range) 
 
Before: 0.5L (0.3-1.0) 
After: 3.0L (2.5-4.0) 
p<0.001 
Proportion receiving antibiotics in <1hr - n/N (%) 
 
Before: 73/245 (30) 
After: 284/426 (67) 
p<0.001 
Andrews, 
201432 
Mean Score 
(+/-SD) 
 
Before: 17.9 
(+/-0.9) 
After: 17.8 (+/-
0.9) 
p=0.95 
n/N (%) 
 
Before: 34/56 
(60.7) 
After: 34/53 
(64.2) 
RR 1.05 (95% CI 
0.79-1.41) 
Adverse changes in respiratory 
status in response to fluids 
(increase in RR or decrease in 
SpO2) n/N (%) 
 
Before: 16/56 (28.6) 
After: 18/53 (34.0) 
p=0.54 
Volume of IV fluids given in first 6 hours - mean no. 
of L (+/-SD) 
 
Before: 1.6L (+/- 1.1) 
After: 2.9L (+/-1.0) 
p<0.001 
Median time to receiving antibiotics from admission 
– hours (range) 
 
Before: 1.3 (0.4-3.0) 
After: 1.5 (0.5-3.7) p=0.42 
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Table 6: Outcomes from catheter care bundle studies in review 
 
 
 
 
Study,  Year 
 
Incidence of CAUTI           
CAUTI rate = n per 1000 
catheter days 
 
Hand hygiene compliance                              
n/N (%) 
Duration of 
catheterisation  
Mean no. of days  
(+/- SD)                     
Process outcomes 
Jaggi, 201236 Before: 11.4  
After: 5.5 
Before: 33.0% 
After:  51.0% 
p=0.0004 
 
Before: 23 
After: 21 
- 
Navoa-Ng, 201339 Before: 11.00  
After: 2.66 
RR 0.24 (95% CI 0.22-0.53) 
p=0.0001 
 
Before:  297/519 (57.23)  
After: 2872/3672 (78.21) 
RR 1.37 (95% CI 1.21-1.54) 
p=0.0001 
Before: 2.9 (+/-4.1) 
After: 2.73 (+/-4.2) 
p=0.52 
Correct positioning of the 
catheter (thigh) – n/N (%) 
 
Before: 389/936 (41.56) 
After: 7485/8425 (88.84) 
RR 2.14 (95% CI 1.93-
2.37) p=0.0001 
Urine bag in hanging 
position – n/N (%) 
 
Before: 389/936 (41.56) 
After: 7775/8425 (92.28) 
RR 2.22 (2.01-2.46) 
p=0.0001 
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Table 7: Outcomes from remainder of studies in review 
 
 
 
Study,  Year 
 
Incidence of infection           
CLABSI rate = n per 1000 
central line days 
Hand hygiene compliance                              
n/N (%) 
Duration of central 
line catheterisation                     
mean no. of days  
(+/- SD) 
Process outcomes 
Warren, 201033 - - 
 
- Total quality of care 
scores for maternal 
health (0-23) 
Before:  3.26 
After: 8.27 
p<0.01 
Total quality of care 
scores for new born 
health (0-11) 
Before:  3.37 
After: 6.45 
p<0.01 
Jaggi, 201337 Before: 6.4  
After: 3.9 
RR 0.61 (95% CI 0.46-.81) 
p=0.0007 
Before:  1467/ 2013 (73) 
After: 17914/21327 (84) 
RR 1.15 (95% CI 1.1-1.22) 
p=0.0001 
Before:  2.53                    
(+/- 4.4) 
After: 2.54 (+/-5.8) 
p=0.9 
- 
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Description of studies 
Only one randomised controlled trial met the inclusion criteria. Andrews et al32 randomised 
patients admitted to the emergency department, intensive care unit and medical wards of 
the national referral hospital in Lusaka, Zambia to receive either usual care or their early 
goal-directed protocol, entitled “Simplified Severe Sepsis Protocol” which included fluids, 
antibiotics and dopamine +/- blood transfusion as required. The study was terminated early 
due to problems with respiratory distress secondary to fluids32. In the non-randomised 
sepsis bundle study by Jacobs et al set in Zambia, negative reactions to fluids were also seen 
as a common adverse effect. 
 
There were nine non-randomised before and after studies included in this review. Three of 
the nine studies37,38,39 used a selected “multi-dimensional approach” from the International 
Nosocomial Infection Control Consortium (INICC),42 a global scientific network whose work 
involves assessing the success of a variety of bundles in a mixture of high and low-income 
settings to reduce the incidence of healthcare associated infections. The INICC supports 
hospitals in low-income countries, in the implementation of programs to reduce healthcare-
associated infection rates. It provides the necessary paperwork and guidance, as well as 
scientific support to hospitals undertaking studies assessing the use of these bundles. All 
three INICC studies used the same format in terms of methodology and outcome reported, 
with patients selected from ICUs in a number of centres. Each paper reported on the use of 
one bundle including: a VAP bundle in India38, a catheter care bundle in The Philippines39 and 
a central line bundle in India37. 
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The remaining five studies with an infection bundle intervention were locally designed, with 
a bundle created specifically for their hospital and setting. Results were reported differently 
for each study however there was commonality in the outcomes measuring including 
incidence of infection (VAP, CAUTI or CLABSI).  This was measured using a standardised rate 
formula: rate = n per 1000 ventilator or catheter or central line days34,36–41 
 
Other common outcomes included the duration of line placement 
(ventilation/catheterisation/central)36–41, in addition to length of stay in the intensive care 
unit (ICU)40,41 and severity score measurement32,40,41. Four studies looked at mortality 
rate21,26,27,32 and three studies identified changes in hand hygiene compliance with the use of 
a bundle36,37,39. Adverse outcomes to the bundle and some process outcomes, such as 
volume of fluids given and time to antibiotics, were also identified in a number of 
studies32,33,35–37,39. 
 
Of the ten studies included, one study described the use of a postnatal package for client-
patient relationships, and compared it’s use to the current care that postnatal women 
receive in rural Kenya33.  
 
VAP bundle studies 
All four VAP bundles contain similar components. There are seven main components to the 
VAP bundles used in these studies, including: 
1. Positioning (including head of bed elevation)34,38,40,41 
31 
 
2. Oral care (e.g. chlorhexidine application)38,41 
3. Daily assessment for extubation (including spontaneous breathing trial)34,38,40,41 
4. Gastric care (i.e. peptic ulcer prophylaxis)34,38,40,41 
5. Deep Vein Thrombosis prophylaxis34,40,41 
6. Daily sedation break34,38,40,41 
7. Equipment hygiene (including maintaining endotracheal cuff pressure, removing 
condensate and using sterile water to rinse respiratory equipment)38 
 
None of the four VAP studies included every VAP bundle item. Mukhtar 2014 included all 
items apart from equipment hygiene41 and Mehta 2013 omitted DVT prophylaxis and daily 
sedation break38. Both Mohamed 2014 and Alsadat 2012 did not include equipment hygiene 
and oral care as part of their bundles34,40.  
 
The Alsadat paper does not give clear information on the number of patients included and is 
not clear on the timeline of introduction of the intervention in its numerous sites therefore 
fewer results were available from this study34. 
 
Sepsis bundle studies 
The two sepsis care bundle studies took place in Africa, one in Zambia32 and the other  in 
Uganda35. The bundles were slightly different in terms of the elements included; however 
the patient characteristics for both studies were quite similar. Both studies included adult 
patients in emergency departments over 18 years old with documented signs of sepsis or 
severe sepsis32,35 and identified similar outcomes as shown in table 5. 
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Catheter care bundle studies 
There were two studies identified using a catheter care bundle, Jaggi 2012 set in India36 and 
Navoa-Ng 2013 set in The Philippines39. Some results from Jaggi 2012 were provided within 
the paper, however the overall number of patients and statistical analysis was not available, 
therefore it was difficult to correctly analyse the data further36. Outcomes reported were 
similar for both studies, as seen in table 6 and the incidence of infection was significantly 
reduced with the use of a catheter care bundle in Navoa-Ng’s study39. 
 
Study Quality 
The randomised controlled trial, Andrews 201432 scored highly when assessed using the 
CONSORT statement extension, showing good reporting quality32. Upon quality assessment 
review using the Cochrane tool for risk of bias assessment for randomised controlled trials28, 
it was found to be overall “low risk” as shown in table 1.  
 
The non-randomised studies were assessed using the TREND statement reporting tool29 and 
the Cochrane tool for assessing risk of bias in non-randomised interventional studies30. The 
studies achieved scores of between 19 to 42 out of 57, according to the TREND statement. 
For several studies, there was lack of detail on eligibility criteria, details of the bundle itself, 
sample size and clear summarised outcomes.  
 
Quality assessment was assessed using the ROBINS-I tool by the Cochrane group for the 
evaluation for the risk of bias in non-randomised controlled studies30. As seen in table 2, the 
majority of studies were classed overall as having a “moderate” bias, which is expected of 
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most non-randomised studies, according to the Cochrane tool30. Areas that demonstrated 
good quality included bias in selection of participants and classification of interventions, 
which were mostly classed as low and moderate bias. However, one study received an 
overall classification of “serious” bias and one study was classed as “critical”, the 
implications of which are explored further in the discussion.  
 
Incidence of Infection 
Seven studies reported on the incidence of infection when using a bundle, compared to 
usual care34,36–41. Of these, five studies were included in a meta-analysis37–41 as two studies 
did not report adequate data and therefore could not be included34,36. The meta-analysis 
showed a significant reduction in the incidence of infection with the use of a bundle 
compared to usual care (rate ratio 0.58, 95% confidence interval 0.48 to 0.70, p<0.001, 
figure 2). Evidence of heterogeneity between the papers was low and not significant.  
(I2=9.7%, p=0.351). 
 
Mortality 
Mortality rate was reported in 4 studies32,35,40,41. One study was excluded from the meta 
analysis due to the limitations in the data provided35.  Of the three studies that were 
included, two were before and after studies40,41 and one was a randomised controlled trial32. 
Given the difference in study design, it was decided to display the results in a forest plot 
without summary measures as as opposed to carrying out a meta-analysis (figure 3). This 
suggests no mortality benefit with the use of the bundle although this has been assessed 
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further statistically and it is not possible to document whether these results are significant or 
not. Only one study reported a significant mortality reduction with the use of a bundle40, 
however without meta-analysis of numerous studies we are unable to analyse this further. 
 
Severity Score (APACHE II) 
Three studies reported the illness severity score (APACHE II), given to patients both before 
and after the use of a bundle32,40,41. Similarly, due to study design differences, these were 
not meta-analysed and the data is presented in the form of a forest plot (figure 4). The figure 
suggests no reduction in the APACHE II score with the use of a bundle. 
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            Figure 2: Incidence of infection using bundled care compared with usual care 
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Figure 3: Mortality rate using a bundle compared with usual care 
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Figure 4: Severity score with the use of a bundle compared to usual care 
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DISCUSSION 
Main findings of the review 
In this systematic review, we looked at the use of different care bundles in low and lower-
middle income countries, compared to usual care. In total, ten studies were included from 
seven low and lower-middle income countries. A number of outcomes were comparable for 
the variety of interventions included within this review. Meta-analysis showed that there 
was a statistically significant reduction in the incidence of infection in five of the nine studies 
that compared the use of a bundle to usual care in the management of various infections 
(rate ratio 0.58, 95% confidence interval 0.48 to 0.70, p<0.001). There was no evidence of 
improvement demonstrated in mortality or severity score with the use of a bundle from 
three studies with different study designs. 
 
Strengths and limitations of the review 
Studying the literature, there are no published systematic reviews looking at the use of care 
bundles, compared to usual care in low and lower-middle income countries. However, over 
the last ten years, there have been a number of important systematic reviews published 
looking into the use of care bundles in the management of sepsis, although mainly in a high-
income country setting. A systematic review of studies conducted in the USA in 2010 looked 
at the use of bundled care in septic shock and identified eight studies in total (a mix of RCT 
and observational studies). Their results were significantly in favour of the use of a sepsis 
bundle in patients with septic shock with a significant increase in survival noted (odds ratio 
1.91, 95% confidence interval, 1.49-2.45, p<0.001). The use of a sepsis bundle was also 
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associated with a decrease in the time to antibiotics and increase in the appropriateness of 
prescribing of antibiotics (p<0.0002)43. 
 
Looking at the prevention of infection using bundles, a recent systematic review published in 
2014 looked at 41 before and after studies using a quality improvement initiative such as a 
care bundle or checklist for the prevention of central line associated bloodstream infections 
(CLABSIs). The authors found that there was a significant infection rate decrease with the 
use of a care bundle or checklist (odds ratio 0.39, 95% confidence interval 0.33-0.46, 
p<0.001). Interestingly, further meta-analysis of results showed an ongoing reduced 
infection rate up to three months post-intervention (odds ratio 0.30, 95% confidence 
interval 0.10-0.88, p =0.03)44. 
 
One of the main strengths of our review is that although the studies included varied in terms 
of location and intervention used, the majority of papers were comparable and this allowed 
us to draw important conclusions within the review. A number of studies used similar 
interventions, allowing us to compare results in different countries and cohorts. Our review 
is one of the first to explore the relationship between the use of a bundle compared to usual 
care, in LMIC and we have grouped together all studies using bundles in a number of LMIC 
including India, Syria, Egypt, The Philippines, Zambia, Uganda and Kenya32–41. This allowed us 
to explore results from these two continents, however these may not be generalisable to all 
LMIC in other continents. Despite the difference between the countries, most of the studies 
concluded the use of a bundle was associated with improved care overall, compared to usual 
care. 
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Another strength of the review is the overall sample size. Although only 10 studies were 
incorporated, the meta-analysis included a large enough number of patients (86,224 from 
the five studies included in the meta-analysis) to show a significant reduction in the 
incidence of infection. This large number of patients also helps outweigh many of the design 
issues associated with the studies selected.  
 
The random effects model was also used, to account for the bias which is routinely a 
problem in observational studies46. In terms of bias in our review, the one randomised 
controlled trial (RCT) that was included in the review was found to be “low” in most bias 
domains according to the Cochrane Tool (table 1). The remaining nine studies were non-
randomised with a before and after design, therefore there is more potential for bias. Many 
of the before and after studies recognised the limitations attributed to the study design, and 
one example is the “Hawthorne effect”, cited by Jaggi 201337, Navoa Ng 201339 and Jacobs 
201335. This refers to the change in behaviour (usually unconsciously) by patients taking part 
in observational research46. The Hawthorne effect is important as it can have a confounding 
effect on the results and affect the generalisability46. 
 
In addition, the use of historical controls (such as those used in Jacobs 201335) has been 
acknowledged to over-estimate the benefit of a new intervention and may in fact provide 
misleading results. 
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On assessing the methodological quality of the non-randomised studies using the Cochrane 
ROBINS-I tool, there was a moderate to serious risk of bias for confounding for all studies, all 
of which had a before and after design (table 2). 
 
Two studies showed higher levels of bias overall and this was due to the methodology and 
reporting of results. Alsadat’s study carried out in Syria, looking at the use of a VAP bundle34, 
received an overall bias score of “serious”. Reasons for this include minimal information 
about the study population including the total number of patients recruited and the actual 
number of patients who developed a ventilator associated pneumonia, both before and 
after the introduction of the VAP bundle34. Percentages were supplied, however without the 
raw figures, there is clear risk of bias in the selection of the reported results.  
 
Similarly, the study by Jaggi looking at the use of a catheter care bundle in India36 scored 
highly, with an overall bias assessment of “critical”. Again, there is minimal information 
provided within this paper and the authors fail to clarify the components of the catheter 
care bundle, making it difficult to compare with other studies. In addition, due to limitations 
in the data provided, there is a high risk of bias in both the selection of the reported results 
and confounding. Numerous attempts were made to contact authors from both papers 
(Jaggi 201236 and Alsadat 201234) to elaborate on the bundles used and numbers of patients, 
but unfortunately no reply was received. As per the ROBINS-I tool, a “serious” or “critical” 
result tells the reader that the study at hand has some “important problems” or is “too 
problematic to provide any useful evidence and should not be included in the synthesis” 
respectively30. It is therefore more difficult to assess the external validity of these studies 
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and the use of them in further synthesis should be avoided, as to prevent skewing of the 
results. 
 
Another limitation of our review is the patient population selected, especially when 
comparing mortality. From the four studies that compared mortality, two studies included 
patients only within the ICU40,41. The other two studies compared patients presenting to 
Medical Casualty35 and Emergency Departments32. Patients requiring intensive care 
treatment tend to be more unwell and therefore these patients may have had a poorer 
prognosis, which could affect the overall mortality rate and therefore this needs to be 
considered when taking into account the results48. 
 
Moreover, this is an important point when thinking about how these results translate to 
other settings within a low and lower-middle income country. The majority of the studies 
included in this review looked at bundles related to nosocomial infections in intensive care 
settings in a LMIC. Therefore, in more resource limited settings such as a health centre or 
district hospital in a LMIC, it is difficult to extrapolate the same results. Intensive care units in 
LMIC are usually found within tertiary hospitals and therefore they may have access to a 
number of facilities which can improve implementation of such infection bundles. These may 
include but are not limited to: an increased number of staff, more experienced clinicans e.g. 
physicians/surgeons and access to more advanced diagnostic tests or interventions that may 
not be available in a health centre or district hospital. 
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Study implications & conclusions 
Our findings suggest that using a bundle in a low or lower-middle income country 
significantly reduces the incidence of infection compared to usual care. This review 
demonstrates care bundles have been used successfully in numerous LMIC and for patients 
with a variety of conditions. However, our review only includes 10 eligible studies and we 
were not able to meta-analyse the results for mortality and severity score to show if there 
was a significant effect with using a bundle due to variations in study desig. Further research 
should be undertaken with a detailed meta-analysis of numerous studies with similar study 
designs to assess whether the use of a care bundle in an LMIC could help to reduce 
mortality.  
 
Given the results from our review, there is scope for the development of LMIC-specific 
bundles for the management of various infections and sepsis. A bundle, which is tailored to 
meet the needs of low and lower-middle income countries, can help to provide a framework 
for managing these conditions and improve the care that these patients receive.  
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CHAPTER 3: DEVELOPING A BUNDLE TO IMPROVE MATERNAL 
SEPSIS CARE IN LOW RESOURCE SETTINGS: AN INTERNATIONAL 
DELPHI CONSENSUS 
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ABSTRACT 
 
Objective:  
To develop a consensus based care bundle for use in the initial management of maternal 
sepsis in low and lower-middle income countries (LMIC). 
 
Methods:  
A systematic search of the literature was completed to create a long-list of possible bundle 
elements. This information was applied to create a comprehensive long-list of contents for 
inclusion in the bundle. A modified three-iteration Delphi method was used to gain 
consensus on the final components. Members of an advisory panel offered advice on the 
contents and questions prior to commencing the Delphi. For round 1, an online 
questionnaire was sent to a practitioner panel of healthcare professionals working in LMIC. 
Participants were asked to rank each element on a Likert scale out of 5 on both importance 
as well as feasibility (in a health centre and hospital setting). In round 2, the same 
questionnaire was sent to a panel of selected international experts in the field. Further 
consensus was built with feedback from meetings with the World Health Organization 
(WHO) maternal sepsis working group. Round 3 of the Delphi involved feeding back the 
results from the first two rounds to all participants, to identify if consensus had been 
reached.  
 
46 
 
Results:  
In total, 143 LMIC practitioners from a number of different cadres in 34 different LMIC 
responded to the round 1 survey; in addition to the 11 members of the international expert 
panel. There was consensus between the views of the practitioners and experts with the 
same items appearing as the most important. Both groups also deemed these items feasible. 
The final items selected were: Fluids, Antibiotics, Source Control and Transport (to 
appropriate higher-level care facility). Monitoring for both mother and baby also scored 
highly, completing the bundle. These final elements were subsequently summarised with the 
acronym FAST-M to assist practitioner recall. 
 
Conclusions:  
A clinically relevant and feasible maternal sepsis care bundle has been developed by 
international consensus. This can be developed into a package to be implemented and 
tested in an appropriate setting. 
 
Keywords:  
low income, lower-middle income, bundle, care bundle, maternal sepsis, sepsis, Delphi, 
consensus 
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INTRODUCTION 
Sepsis is the third most common direct cause of maternal mortality, accounting for 10% of 
maternal mortality worldwide, but is a contributing factor in multiple other causes of 
maternal death2. As mentioned in chapter one, the definitions for sepsis have recently 
changed to reflect the ongoing developments in sepsis care research over the last ten years. 
These new definitions and criteria were produced to help improve sepsis recognition and it’s 
management world-wide and have shown to be especially useful in treating sepsis. 
 
Maternal sepsis can occur in women during pregnancy or the puerperium and is a challenge 
due to the differing physiology of women during pregnancy; meaning determining levels of 
organ dysfunction can be difficult8. Therefore having a robust definition, such as the one 
recently developed by the WHO1, can offer clinicians a way of identifying these women and 
initiating treatment rapidly.  
 
In order to manage sepsis effectively, a number of care bundles have been produced that 
have been used with success, specifically in high-income countries. Examples include the 
“Surviving Sepsis” campaign and “Sepsis Six”, which have demonstrated an impressive and 
consistent ability to nearly double survival through the introduction of care bundles21,43. 
These have not yet been adapted for a maternal population, and the resources do not 
generally exist to implement the existing bundles in low-income settings. A bundle 
specifically designed for use in low and lower-middle income countries can standardise and 
improve the care that pregnant women receive. It may also help decrease mortality from 
sepsis during pregnancy and the puerperium. 
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To develop this bundle, we proposed to form consensus and elicit the views of practitioners 
and experts in the field using a modified Delphi technique. Consensus forming methods aim 
to bring groups together in order to agree on a certain action or decision49. The Delphi 
method involves members of the groups completing questionnaires or being interviewed in 
order to narrow down the material offered to agree on a conclusion. Participants then 
review a report of results and can further amend or justify their responses.  
 
Thangaratinam describes the Delphi method as “a way of obtaining a collective view from 
individuals about issues where opinion is important50”. The anonymity of stakeholders is 
important and the identity of Delphi members should not be revealed to others undertaking 
the questionnaires, to reduce the risk of bias and the subsequent effects on the answers. 
The Delphi technique is often composed of a number of iterations (usually between two to 
three) until a consensus and decision is made. It has been used in a range of situations in 
clinical practice, for example in creating evidence based guidelines for use in many different 
medical specialties, including Obstetrics and Gynaecology50. 
 
The aim of this study is to use the Delphi method to develop a consensus and evidence-
based maternal sepsis bundle, optimised for use in low and lower-middle income countries. 
We want to ensure the bundle is: suitable to integrate with existing practices; easy to 
implement; practical enough to initiate in both a health centre and hospital setting and 
suitable for use in women during pregnancy and the puerperium, presenting with signs of 
maternal sepsis. 
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METHODS 
 
We undertook a modified three-iteration Delphi study to gain consensus on the most 
appropriate items to be included in the low-income country maternal sepsis bundle. The 
process comprised of three rounds. The first iteration included a consultation with a broad 
panel of practitioners who care for women with maternal sepsis, in low and lower-middle 
income countries (LMIC). This was followed by seeking the opinion of a group of selected 
experts in the field and a final round comprising of further consultation with all participants 
to ascertain their final opinions on the chosen components of the bundle. 
 
Selection of Delphi Items 
In order to determine the various items that may be included for consideration in the Delphi, 
the steering committee undertook a systematic search of the literature. A comprehensive 
long-list of possible contents was compiled by reviewing all current literature on sepsis in 
low and lower-middle income countries, as well as consulting many books, guidelines and 
protocols from a number of countries including the UK, India, Tanzania and Malawi. Multiple 
resources were used until saturation had been reached6–8,16,17,19,20,25,51–135 
 
The items were grouped into the following categories: Fluids, Monitoring, Breathing, 
Positioning, Source Control, Prophylaxis, Recovery, Resources, Drugs, Communication and 
Diagnosis. The initial list was analysed by the steering committee, which removed duplicates 
and grouped similar items. 
50 
 
 
This long-list of potential items was shared with an advisory panel of experts in global 
maternal health, including doctors and clinical academics working in intensive care, 
neonatology and obstetrics. The advisory panel’s role was to provide guidance on the 
components put forward for consideration. It was felt this was necessary prior to sending 
the questionnaire out to ensure the most appropriate resources were used and no items 
were omitted. 
 
Comments from the advisory panel were received, with useful edits and changes to be 
made. They advised to exclude three items that were seen to be inappropriate and definitely 
unfeasible to be included in an LMIC bundle. These included: the use of intravenous 
immunoglobulin (which is shown to have an immunomodulatory effect) due to realistic lack 
of availability in low resource settings8,79,136. In addition, the use of vasopressors was 
excluded (for example norepinephrine and oral midodrine) which again is unlikely to be 
available in a low resource setting3,18,23,52,59,61,69,74,120–123,135. Central venous monitoring (to 
aim for central venous oxygen saturations of >70% and to monitor haemodynamic signs such 
as cardiac output and central venous pressure) was also excluded due to limited availability 
of level three care (equivalent to receiving treatment in an intensive care unit)14,69,74,80,135,136.  
The advisory panel also advised monitoring of the neonate to be considered as an extra 
monitoring point.  
 
A final list of items was created and formed into questions to be put forward to stakeholders 
in rounds 1 and 2. Figure 5 outlines the process from selection of initial items to the first two 
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rounds of the Delphi process. Figure 6 shows the remainder of the process culminating in 
consensus being reached on the final components.  
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Figure 5: Flowchart showing selection of bundle items using Delphi method 
Initial long listing of possible Delphi items for inclusion obtained 
through systematic search using over 100 resources (n=216) 
Duplicates removed and similar items 
merged (n=153) 
Long listing put forward for review by steering committee (n=63) 
 
Further grouping and items removed by 
committee (n=23) 
 
Final condensed grouping of items (n=40) 
 
Advisory panel review condensed 
grouping. Removal of three items 
(immunoglobulins, vasopressor use and 
central venous monitoring). Addition of 
one item (monitoring of neonate). 
 
Final items to be put forward in Delphi questionnaires (n=38)  
 
 
First round of Delphi 
questionnaire sent to 
Practitioner Panel 
 
Second round of Delphi 
questionnaire sent to 
Expert Panel 
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Figure 6: Flowchart showing the process of the three Delphi rounds 
Third and final round of Delphi 
completed by members from both 
panels (n=66) 
First round of Delphi 
completed by members of 
Practitioner Panel (n=143) 
 
 
Second round of Delphi 
completed by Expert Panel 
members (n=11) 
 
 
Consensus reached on the most 
important and feasible treatment items 
(n=4) and monitoring items  (n=7) 
Delphi process completed and final 
items selected for inclusion into low-
income maternal sepsis bundle 
components  
Results of first and 
second round fed back 
to both panels for 
consideration 
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Round One 
In December 2015, an online questionnaire was produced (using Smart SurveyTM138). The 
survey was distributed to healthcare workers based in low and lower-middle income 
countries; or practitioners in high-income countries who have had experience and have 
worked in low-income settings. We used the World Bank classification26 to identify the 
countries that were classed as low and lower-middle income. A large cohort of contacts was 
gained through professional networks, literature reviews and online searches. The 
questionnaire was cascaded via email to hundreds of eligible contacts and many of the 
practitioners from South America and Malawi were given the link to the survey via 
colleagues and so the network grew. In total, 386 emails were sent, however this is a rough 
estimate and it is difficult to know the exact number given the snow-balling of the email to 
relevant participants who may have been interested. An information sheet was attached to 
the email to provide additional information about our project (appendix 2) and an email 
address was also provided so that respondents could ask questions if required. Reminder 
emails were sent every four weeks and a deadline was given for the end of February 2016 
(two months after the survey opened) to encourage participants to respond in a timely 
manner.  
 
We asked our practitioner panel introductory questions to ascertain their background and 
range of practice. We then asked four main questions and invited them to offer ideas in free 
text responses throughout the questionnaire. The questions asked respondents to give a 
score for each included possible item (using a Likert scale out of 4 or 5) in terms of both 
importance and feasibility in both a health centre and hospital setting, for the immediate 
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management of maternal sepsis (within 3 hours of admission). The full questionnaire can be 
found in appendix 3. Respondents were from a number of cadres including Obstetricians, 
Clinical Officers, Nurses, Midwives, Nurse-Midwives and Scientists and Researchers. Implicit 
consent to participation was considered upon taking the survey. There was no incentive 
offered to participants completing the survey. 
 
Round Two 
Round two commenced in February 2016. For our second round, we hand-selected a group 
of internationally renowned experts within the field of global health, sepsis and obstetrics 
and gynaecology. The steering committee suggested international authorities in these fields 
and selected the most recognised, widely published academics. An email was sent to all 
experts, outlining the project and progress thus far and asking if they would like to be part of 
the Delphi process. We did not reveal the results from round one, as we did not want to 
introduce any response bias or lead the expert panel’s answers in any way. In addition to the 
Likert scale questions, we took into consideration the comments received from the expert 
panel and compared them with those from the practitioner panel. 
 
Immediately after completion of round two, the committee attended a meeting at the World 
Health Organization (WHO) in Geneva, Switzerland, with the Maternal Sepsis Working Group 
(now called the Global Maternal and Neonatal Sepsis Working Initiative). At this meeting, 
discussions took place regarding the future of maternal sepsis research, especially in 
developing countries. In order to gain expert opinion on the progress and preliminary results 
56 
 
of the Delphi thus far, opinions were sought from members of the WHO team. There was 
general agreement on the initial elements to be included within the bundle. There was no 
formal voting or consensus forming activity undertaken here, however expert feedback and 
reassurance was obtained which was useful for the remainder of the Delphi process. It did 
not influence the answers or responses obtained from any of the three rounds. 
 
Round Three 
Following completion of the first two rounds, a report was produced outlining the answers 
to the Likert scale questions in the form of a 100% stacked bar chart. Bar charts were 
produced for importance and feasibility (in both a health centre and hospital setting) for 
both the practitioner and expert panels (figures 9-14 and 17 & 18). In addition, scatter plots 
were created to outline the relationship between importance and feasibility for the 
practitioner panel (figures 15 & 16 and 19 & 20). Tables showing the statistically most 
important elements were also provided, showing the rank given to the top 5 treatment and 
top 7 monitoring items, in addition to the mean and standard deviations derived for each 
item (tables 8 and 9).  
 
This information was provided to all participants from the first and second rounds to ensure 
they were able to provide informed answers to the final round. The third round was 
circulated in March 2016 and asked participants if they agreed with the final items presented 
and invited them to offer ideas on additional or missing items. A copy of the questionnaire 
distributed in round three can be found in appendix 4. 
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RESULTS 
Overall, 154 stakeholders from 34 countries offered their opinions through online 
questionnaires over three rounds of our modified Delphi study. Consensus on the final 
aspects of the bundle was reached following the second round and was confirmed in the 
third and final round.  
 
Practitioner Panel Round 
In total, 143 final responses were received in the practitioner panel round from a number of 
different cadres. Demographics included obstetricians (57% n=81), clinical officers (19% 
n=27), nurses/midwives/nurse-midwives (8% n=12) as well as general doctors (5% n=7). 6% 
(n=8) of recipients classified themselves as “other” (such as: paediatrician, infectious disease 
specialist, matron) and the remaining responses were from scientists/researchers (4% n=6) 
or those who worked in administration or managerial roles (1% n=2).  
 
Respondents were from over 34 different low and lower-middle countries in Europe, Asia, 
Africa, North and South America, showing good overall global coverage. Many stakeholders 
who responded had worked in more than one LMIC and had noted their answers were based 
on their experiences in a number of countries, including LMIC. Figure 7 shows the proportion 
of responses from each continent. Our results show that 63.8% of responses were from 
Africa - with just under a third of total responses (30.3%) coming from Malawi. Asia 
represented 14.5% of responses incorporating countries such as Pakistan, India, Sri Lanka 
and others. The remainder of the results were from Europe (including the UK and Belgium - 
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12.5%), South America (including LMICs such as Honduras, Bolivia, Nicaragua and El Salvador 
- 7.9%) and North America (USA & Haiti - 1.3%).  
 
Most practitioners in this round stated that they worked in a tertiary centre (with specialist 
services) (45.5% n=65) or district general hospital (38.5% n=55). A small percentage worked 
in a health centre (3.5% n=5) or community setting (4.9% n=7) and there were a number of 
respondents who identified as “other” (7.6% n=11). Those in the “other” category were 
either retired, worked in a university or an NGO or in management (figure 8). 
 
When asked if they had managed a patient with maternal sepsis in the last six months, 
76.9% (n=110) of stakeholders responded “yes”, suggesting the majority of the practitioner 
panel have had recent, relevant clinical experience.  
 
Following the initial questions, practitioners were asked to give a score on the importance 
and feasibility of the possible bundle items using a Likert scale. Firstly, they were asked to 
select a score between 1 and 5 for the importance of all 38 items (13 treatment items and 25 
monitoring items), where 1 = very un-important and 5 = very important. They were then 
asked to assign a score between 1 and 4 to the feasibility of all the items, where 1 = 
definitely un-feasible and 4 = definitely feasible (see appendix 2). 
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Figure 7: Pie chart showing proportion of Round 1 respondents from different continents 
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Figure 8: Bar chart showing the places of work of Round 1 respondents 
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The scores given for the treatment items and monitoring items are shown in figures 9 and 
10, respectively. Data is presented as 100% stacked bar charts with colours corresponding to 
the score given. The percentage highlighted indicates the proportion of respondents giving a 
score of 5/5 – “very important”. 
 
The results for the feasibility of both treatment and monitoring items in a health centre and 
hospital setting are depicted in figures 11-14. For the purpose of this study, a health centre is 
a facility which aims to provide basic emergency obstetric care (BEmOC) which includes a 
number of interventions such as the administration of antibiotics or uterotonic drugs, 
manual removal of the placenta and retained products and basic neonatal resuscitation 
care139. Vaginal deliveries, including assistance with vacuum139, would usually take place, as 
well as routine antenatal and post-natal care but there is no recourse to caesarean section. 
There may be non-physician clinicians present as well as nurses and midwives; however it is 
unlikely there will be any doctors working at this sort of facility. 
 
Again, data is presented as 100% stacked bar chart with colours corresponding to the score 
given. The percentage highlighted indicates the proportion of respondents giving a score of 
4/4 - “definitely feasible”.  
 
Figure 9 demonstrates the 5 most important treatment items, as selected by the 
practitioner panel. The most important item was the administration of early antibiotics, with 
96.5% of practitioners giving it a score of 5 from 5 (very important). The second most 
important item was venous access (91.6% scoring 5) followed by administration of 
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intravenous fluids (82.5% giving a score of 5). This was followed by the correct identification 
of the source of infection (69.9% scoring 5) and finally transport to the most appropriate 
location (62.9% giving a score of 5). 
 
In terms of feasibility, practitioners highlighted the most feasible treatment items in a health 
centre as shown in figure 11. Giving an antipyretic medication was seen as most feasible, 
with 72% of practitioners giving a score of 4 from 4 (definitely feasible). Obtaining venous 
access and administration of intravenous fluids was also deemed as feasible (72% and 71.3% 
respectively). 65.7% of practitioners also gave correct positioning of the patient and 
administration of antibiotics a score of 4.  
 
These top five treatment items were also deemed as the most feasible in a hospital setting, 
although in a slightly different order with venous access seen as the most feasible item in a 
hospital and antipyretics as the fifth most feasible item (figure 13).  
 
Moving on to the most important monitoring items, it was found that the measurement of 
blood pressure was seen as the most important with 90.2% of practitioners giving a score of 
5 from 5 (very important) as shown in figure 10. 89.5% of practitioners gave measurement of 
respiratory rate and heart rate a score of 5 along with 82.5% for the measurement of urine 
output. Assessment of conscious level was also seen as very important with 81.1% of 
practitioners giving it a score of 5. 75.5% of practitioners also gave measurement of 
temperature the very important score. 
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In addition to these top five items, monitoring of the baby, measurement of white cell count 
and oxygen saturation also scored highly in terms of importance.  
 
Looking at the feasibility of monitoring items, there were some differences seen with the 
ranking between a health centre and hospital setting. Figure 12 shows the top five most 
feasible items in a health centre to be measurement of blood pressure, with 79.7% of 
practitioners giving it a score of 4 (definitely feasible), along with the measurement of 
temperature. 79% of practitioners gave measurement of respiratory rate and heart rate a 
score of 4 and 69.9% gave this score to assessment of conscious level. Finally, 57.3% of 
practitioners gave malaria testing a score of 4. 
 
In a hospital setting, measurement of urine output was seen as more feasible than malaria 
testing, in terms of its ranking amongst all the monitoring items (figure 14).  
 
We looked at the relationship between importance and feasibility for both treatment items 
(figure 15) and monitoring items (figure 16) in both a health centre and hospital setting. 
These scatter plots graphically represent the percentage of respondents who scored an item 
as “definitely feasible” against the percentage scoring the item as “very important”. 
 
It is interesting to see there are three main treatment items that are seen as both “very 
important” and “definitely feasible” – obtaining venous access, administering antibiotics and 
IV fluids. A number of items that were seen as very important were also reasonably feasible, 
including ensuring appropriate location for care and appropriate positioning (figure 15). 
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In terms of monitoring, there is a clear correlation demonstrated between importance and 
feasibility in five items – measurement of blood pressure, measurement of respiratory rate 
and heart rate, urine output, conscious level and measurement of temperature.  It is 
reassuring that the most important and feasible treatment and monitoring items are 
interventions that are practical and possible in a lower income setting. 
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Figure 9: Results from the first round Delphi survey regarding the importance of treatment items using a Likert scale 
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Figure 10: Results from the first round Delphi survey regarding the importance of monitoring items using a Likert scale 
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Figure 11: Results from the first round Delphi survey regarding the feasibility of treatment items in a health centre setting using a Likert 
score out of 4 
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Figure 12: Results from the first round Delphi survey regarding the feasibility of monitoring items in a health centre setting using a Likert 
score out of 4 
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Figure 13: Results from the first round Delphi survey regarding the feasibility of treatment items in a hospital using a Likert score out of 4 
45.50%
58.70%
61.50%
66.40%
68.50%
79.70%
79.70%
80.40%
81.80%
87.40%
88.10%
90.20%
90.20%
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Consider assisted ventilation (if required)
Give low-dose steroids
Ensure appropriate location for care (e.g. referral to hospital
or HDU)
Identify and remove the underlying source of infection
Consider a blood transfusion (if required)
Give Oxygen
Give tetanus toxoid (if exposed to tetanus)
Give analgesia
Give antipyretic
Ensure appropriate positioning of the patient
Administer antibiotics early
Administer Intravenous Fluid
Obtain venous access
1= definitely un-feasible
2 = un-feasible
3 = feasible
4 = definitely feasible
70 
 
 
 
 
Figure 14: Results from the first round Delphi survey regarding the feasibility of monitoring items in a hospital using a Likert score out of 4 
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Figure 15: Scatter plots showing the relationship between importance and feasibility of treatment items in a hospital and health centre 
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Figure 16: Scatter plots showing the relationship between importance and feasibility of monitoring items in a hospital and health centre
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Expert Panel Round 
In order to compare results, we analysed the answers from the expert panel identically to 
the practitioner panel. 
 
We received 11 responses from our selected expert panel. Experts were from a variety of 
backgrounds with 63.6% (n=7) of responses from obstetricians, 18.2% (n=2) from other 
specialist doctors (infectious diseases & paediatrics), 9.1% (n=1) from intensive care/ 
anaesthetic doctors and 9.1% (n=1) from scientist/researchers. Respondents were mainly 
based in higher income countries such as the UK and Canada, but had experience in 
countries such as Malawi, Uganda, Nigeria, Kenya, Ghana, India, Pakistan, Bangladesh and 
Thailand. Although members of the expert panel may not be currently practicing a low or 
lower-middle income country, they had all had experience in implementation of similar 
projects and other global health projects, pertaining to sepsis and maternal health.  
 
As members of the expert panel were not working in low-income settings, only their 
responses regarding each item’s importance were analysed. 
 
It was found that the top five most important treatment items matched those of the 
practitioner panel exactly, with administration of antibiotics, venous access, administration 
of fluids, identifying the underlying source of infection and appropriate location of the 
patient being selected, as shown in figure 17.  
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In terms of monitoring, the top five most important monitoring items, that experts scored 5 
out of 5 included assessment of conscious level (81.8%) and measurement of respiratory 
rate and heart rate (81.8%), as shown in figure 18. 63.6% of experts gave the following 3 
items a score of 5: monitoring of baby, measurement of urine output and measurement of 
blood pressure. 
 
Measurement of temperature and oxygen saturation also scored highly for importance. 
Although the order is slightly different, the top seven items were exactly the same for both 
the practitioner and expert panel. This again indicates agreement between the panels in 
terms of the most important treatment and monitoring factors. 
 
When looking at the relationship between feasibility and importance, there were some 
interesting conclusions. In an identical pattern to the practitioner panel, the expert panel felt 
that the top three most important and feasible treatment items included administration of 
antibiotics, venous access and administration of IV fluids in both a health centre and hospital 
setting. The scatter plot in figure 19 also shows a number of other items that were deemed 
both important and feasible including appropriate location of the patient, giving an 
antipyretic and giving tetanus toxoid if required. 
 
In terms of monitoring, the most feasible and important items found by the expert panel 
were also found to be exactly as the practitioner panel had recommended with the top 
items for a health centre being: measurement of blood pressure, measurement of 
respiratory rate and heart rate, assessment of conscious level and measurement of 
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temperature. Figure 20 also shows that, in a hospital setting, the measurement of urine 
output was also seen to be a very important and feasible item. These five items match the 
pattern of the most feasible and important items selected by the practitioner panel, 
indicating general consensus at the end of round two. 
 
We created two tables (table 8 & 9) showing with the ranking of the most important 
treatment and monitoring elements, according to the mean and standard deviation score 
applied to each item, by both the practitioner panel and the expert panel.  
 
Table 8 shows that both the practitioner and expert panel have ranked these same items as 
the top five most important treatment items. Similarly, table 9 shows statistically, both 
panels ranked the same top seven monitoring items, although in a slightly different order. 
 
These tables, in addition to the graphs, suggest that general consensus between both panels 
had been confirmed at the end of round two. However, a final round was required to 
confirm these findings, whereby members from both panels received detail feedback on the 
results thus far and were asked their final opinion in the form of a final questionnaire (see 
appendix 4).  
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Figure 17: Results from the second round Delphi survey regarding the importance of treatment items using a Likert scale out of 5 
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Figure 18: Results from the second round Delphi survey regarding the importance of monitoring items using a Likert scale out of 5 
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Figure 19: Scatter plots showing the relationship between importance and feasibility of treatment items in round two 
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Figure 20: Scatter plots showing the relationship between importance and feasibility of monitoring items in round two
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Table 8: The most important treatment items selected by both panels 
 
 
Practitioner Panel Rank Expert Panel 
Antibiotics 1 Antibiotics 
Mean = 4.90, SD 0.58 
 
Mean = 5.00, SD 0.00 
IV Access* 2 IV Access* 
Mean = 4.83, SD 0.69 
 
Mean = 5.00, SD 0.00 
IV Fluids 3 IV Fluids 
Mean = 4.71, SD 0.76 
 
Mean = 4.64, SD 0.48 
Source Control 4 Location 
Mean = 4.56, SD 0.82 
 
Mean = 4.36, SD 0.64 
Location 5 Source Control 
Mean = 4.39, SD 0.97 
 
Mean = 4.09, SD 1.16 
 
 
*IV access will be removed from the final ranking, as it is intrinsic to two other top ranked 
elements (administration of IV fluids and IV antibiotics). 
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Table 9: The most important monitoring items selected by both panels 
 
Practitioner Panel Rank Expert Panel 
Blood Pressure 1 Respiratory Rate & Heart Rate 
Mean = 4.85, SD 0.58 
 
Mean = 4.82, SD 0.39 
Respiratory Rate & Heart Rate 2 Conscious Level 
Mean = 4.80, SD 0.70 Mean = 4.82, SD 0.39 
 
Urine Output 3 Urine Output 
Mean = 4.73, SD 0.69 Mean = 4.64, SD 0.48 
 
Conscious Level 4 Monitoring of Baby 
Mean = 4.71, SD 0.71 
 
Mean = 4.64, SD 0.48 
Temperature 5 Blood Pressure 
Mean = 4.65, SD 0.75 Mean = 4.55, SD 0.66 
 
Monitoring of Baby 6 Temperature 
Mean = 4.46, SD 0.94 Mean = 4.27, SD 0.96 
 
Oxygen Saturation** 7 Oxygen Saturation** 
Mean = 4.38, SD 1.00 Mean = 4.27, SD 0.96 
 
 
 
** Oxygen Saturation was ranked highly in terms of importance and following the discussion 
at the WHO meeting in February, it was suggested that while not always feasible, it should 
be carried out if the facilities are able to do so. 
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Final Round 
Upon completion of the first two rounds, we sent out a final questionnaire to all who 
participated, and achieved a good response rate. In total 39.9% (n=57) of practitioners from 
the first round and 81.8% (n=9) of experts from the second round replied, with a total of 66 
responses overall. 
 
The questions presented the final components of the maternal sepsis bundle, given the 
results ascertained from the first two rounds. We asked all participants if they agree with 
the final components by answering either “yes” or “no” to the presented treatment and 
monitoring items. We also asked if there were any further comments or if any elements 
should be added or removed.  
 
Results showed that 96.5% (n=55) of practitioners agreed with the final treatment 
components selected with 2 participants disagreeing. One practitioner provided no further 
comment and the other practitioner expressed that “IV fluids are not always necessary”.  
 
Regarding monitoring items, 98.2% (n=56) of the practitioner panel agreed with the final 
selection, with the one practitioner disagreeing and leaving no comment, as with the 
treatment items. The remaining 56 practitioners had no concerns. Minimal comments 
regarding additional bundle elements were given, and the comments that were provided 
suggested emphasis on early administration of antibiotics and concerns regarding feasibility 
of oxygen saturation (expressed by 2 practitioners). 
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Regarding the expert panel, 100% of the respondents (n=9) agreed that the final treatment 
and monitoring items were suitable and had no further comments. 
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DISCUSSION 
This global modified Delphi on maternal sepsis included a consultation with numerous 
stakeholders from the 34 low and lower-middle income countries. The results from this 
study have highlighted the most important and feasible items to be included within a 
maternal sepsis management bundle for use in these countries. 
 
Each of the following items are key interventions that can be undertaken in most health 
centres and hospitals in low and lower-middle income countries. The components below 
were selected to be included in the final bundle: Fluids, Antibiotics, Source Control, 
Transport and Monitoring (for both mother and baby). These items can be grouped together 
with the acronym, FAST-M to assist in practitioner recall. 
 
Fluids 
It is well recognised that the administration of intravenous fluids is an important part of 
sepsis management16,19,20,52,69,74,75,77,135,137,140. From our study, we can see that 82.5% of our 
practitioners and 63.6% of experts felt that fluids were “very important”. In terms of 
feasibility, 71.3% of practitioners felt that the administration of fluids were “definitely 
feasible” in a health centre compared to 90.2% in a hospital, showing in the majority of 
cases, practitioners would recommend the use of fluids. Other sepsis bundles recommend 
the use of intravenous fluids, specifically the Surviving Sepsis Campaign “Resuscitation 
Bundle22” and UK Sepsis Trust “Sepsis Six Bundle13”. In the literature, crystalloids are usually 
advised as a first line fluid, at a rate of 30ml/kg22. However, in resource-limited settings 
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where monitoring of the adverse effects of fluids may prove difficult, it is important to 
ensure safety is paramount, therefore this dosing may be inappropriate. It would be 
advisable to begin with a bolus of 500ml of a crystalloid fluid and reassess, increasing the 
fluids as required and undertaking the appropriate examination and monitoring to look for 
fluid overload including pulmonary oedema, with the resources available. 
  
Antibiotics 
From our results, we can see the highest ranking component was the administration of 
antibiotics. This is ideally through the intravenous route and early on in the management 
plan. It is well documented that the use of IV antibiotics is associated with reduced 
mortality3,7,9,16,52–56,62,64,69,74,77–80,111,112,115,135–137,140. There was clear consensus between both 
panels as 100% of experts felt that antibiotics were “very important”, along with 96.5% of 
practitioners. Practitioners believed that in both a health centre and hospital setting, it 
would be “definitely feasible” to administer antibiotics, with a total of 65.7% and 88.2% of 
practitioners suggesting this, respectively. Bundles such as “Sepsis Six” advise the 
administration of antibiotics as early as possible, or within the first hour13. This is supported 
by evidence in the literature that associates the early administration of antibiotics with 
reduced mortality. Kumar et al undertook a retrospective cohort study over 15 years and 
found that there was a strong relationship between delayed antibiotic initiation and in-
hospital mortality (adjusted odds ratio 1.12, 95% confidence interval 1.10-1.14 p<0.0001)114. 
Giving antibiotics within the first hour of documented hypotension was associated with a 
survival rate of 79.9% and for every hour of delay over 6 hours; there was an average 
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decrease in survival of 7.6%114, highlighting the incredibly important need to initiate 
antibiotic therapy early in sepsis management.  
 
Source Control 
Early identification and removal of the source of infection can help to ensure earlier 
treatment and improved survival rates52,53,66,69,72,79,96,98,135–137,140. From our Delphi study, we 
can see that 54.5% of experts and 69.9% of practitioners felt that source control was “very 
important”. However, practitioners believed this was less feasible to do in a health centre 
setting with 17.5% selecting the “definitely feasible” option, compared to 66.4% in a hospital 
setting. This may be due to the need for diagnostic skills and equipment to identify the 
source of the infection, which may be difficult in more rural health centres. However, there 
are still aspects of source identification and control, which may be feasible in a health 
centre, including bedside testing and manual vacuum aspiration (MVA) post miscarriage. The 
discrepancies between what is available at both facilities highlights the need for adequate 
communication and transport in order to refer patients requiring more specialised care, to 
larger or tertiary centres. 
 
Transport 
The appropriate location for care is important, as the facilities the patient initially attends 
may not be able to provide the appropriate care. The location of the patient can refer to 
transfer from a health centre to a hospital or even within a hospital to a unit that may be 
able to provide advanced care such as a high dependency or intensive care unit. Identifying 
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the correct level of care for a patient is important to ensure the correct treatment can be 
commenced rapidly8,9,16,24,51,52,58,65,66,69,70. 45.4% of experts and 62.9% of practitioners felt 
that transport was “very important” and hence one of the top rated items. In terms of 
feasibility, as per the other items, more practitioners felt that the appropriate location was 
“definitely feasible” in 61.5% of cases for hospitals and 44.8% in health centres.  
 
There are a number of reasons to explain why practitioners may have felt this way. Studies 
and reviews have highlighted the challenges people in low and lower-middle income 
countries face when requiring transport. One of the main reasons this might be more of an 
issue in a health centre is due to its location. Health centres are likely to be in a more rural 
area or serve a smaller population. This can be a problem in terms of the time it would take 
to get to the hospital itself as well as the waiting time for a suitable mode of transportation 
to complete the journey. 
 
A recent systematic review on emergency maternal transport in low-income countries 
identified this issue as one of the main themes and barriers to emergency transportation. 
Additionally the lack of transport options, especially in a rural area, was highlighted to be 
another major factor affecting transportation, as well as full vehicle occupancy being an 
issue. Community and cultural practices also play a part in delaying successful 
transportation, with problems such as drivers refusing to take patients for fear of litigation in 
case of death, and certain beliefs about bad luck and modes of transportation being the 
main concerns141. 
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Monitoring 
There were a number of important and feasible items selected by both the expert and 
practitioner panels (as seen in table 9). The steering committee believed that the concept of 
monitoring should be included within the bundle, as a reminder to clinicians of its 
importance. The monitoring of a patient is key to evaluating the need for and response to 
treatment. Other sepsis bundles include the use of monitoring techniques such as measuring 
hourly urine output or checking lactate levels13, in order to ensure users remember these 
important actions and act on them accordingly. 
 
In a low-income setting, even the most basic of monitoring may be omitted and this can be 
due to a number of reasons, including lack of equipment or training. Therefore, including 
these within the bundle ensures users are aware of their importance and encouraged to 
carry them out. The individual elements to be monitored have been noted as per the Delphi 
results and it is suggested these elements should be monitored first.  
 
Other sepsis bundles, such as “Sepsis Six” have developed toolkits and documentation 
according to the location of the patient e.g. in the community or in the emergency 
department and provide guidance accordingly51,70. Similar implementation tools will be 
necessary for the implementation of this low-income maternal sepsis bundle. 
 
Many studies have looked at sepsis care in low-resource settings and have worked on 
developing specialised care bundles for this setting, although not necessarily for obstetric 
patients. For example, in 2012 Dünser et al collaborated with a global working group in 
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intensive care to develop recommendations for sepsis care in low-resource settings16. 
Structured literature reviews and discussions were held with leading practitioners in sepsis 
and intensive care. The outcome was two suggested care bundles to be used in sepsis 
management in resource-poor settings. This included the “acute care bundle” comprising of 
oxygen therapy, fluid resuscitation, early and adequate antimicrobial therapy and surgical 
source control16. The “post-acute care bundle” comprised of re-evaluation of antimicrobial 
therapy, deep vein thrombosis prophylaxis, glucose control and weaning of invasive 
support16. 
 
The low-income maternal sepsis bundle could be categorised as an acute care bundle as it is 
advised to be used within 3 hours of admission, and therefore post-acute care is not covered 
within our bundle. It is interesting to see that the final components of this bundle comprise 3 
of the 4 items suggested by Dünser. Oxygen therapy was deemed as fairly feasible and not 
very important by our Delphi stakeholders in both rounds (as seen in figures 15 and 19) and 
therefore did not make the final bundle. It is well known that sepsis is associated with the 
disordered delivery of oxygen to tissues12. Sepsis bundles such as the “Sepsis Six13” 
recommend the empirical administration of oxygen to keep oxygen saturations within 
normal levels (94-98%) and maintain good oxygenation. However, the equipment required 
to assess oxygen saturation and deliver oxygen are less available in low or lower-middle 
income countries and the costs of using such a sparse commodity are seen as lower down in 
the list of interventions that are the most feasible and important in the initial management 
of maternal sepsis. 
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Various implementation tools can be used to assist in the delivery of such a bundle. For 
example, a flow chart or checklist may assist in ensuring all steps have been carried out, 
listing them in an easy-to-read manner for the user. This can be especially useful in terms of 
monitoring, whereby practitioners may forget to measure and document important vital 
signs. Using such tools can allow practitioners to document the measurements they have 
taken and show when to act on certain results. Although advantages of using these tools are 
clear, in a low-income setting, the availability of the materials could be an issue. In addition, 
practitioners will require training on how to document and when to act on the results and 
escalate further. 
 
Strengths & Limitations 
There are strengths and limitations to our study. Our Delphi study included a large number 
of participants from many different backgrounds, showing diversity within both of our 
stakeholder panels. The breadth of our responses shows that our results may be generalised 
to a large number of low and low-income countries. On the other hand, identification of the 
majority of the practitioner panel relied upon stakeholders cascading the link to fellow 
eligible colleagues, therefore the cohort sampled may not represent the full potential of the 
population. 
 
In terms of sample size, according to the literature, many similar Delphi studies have had 
comparable numbers. Overall, 154 stakeholders were included in our Delphi study, which is 
alike to the recently published “global health competencies for postgraduate doctors” Delphi 
study carried out by Walpole et al in 2016142.  This study sampled 250 doctors and other 
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health professionals in a similar modified Delphi approach with online and face-face 
consultations to determine global health curriculum items for postgraduate doctors in the 
UK. However, this is dependent upon the specific project as for example, a Delphi study 
carried out to establish consensus on the diagnostic criteria for Carpal Tunnel Syndrome, 
published in the USA in 2003, only included 14 stakeholders as they were looking to involve 
only specialists in the field143. 
 
Another strength of our project is that we were able to reach consensus in just three 
iterations, ensuring we were able to reach a conclusion rapidly and with a clear consensus 
on the critical items for inclusion. The fact that we were able to complete the rounds online 
and not require face-face or telephone interviews also worked to our advantage, as it saved 
us time in obtaining results. In contrast, a limitation to the online responses, is that we 
missed out on the opportunity to discuss various questions face-face and transcribe the 
answers, which may have given us more detailed information that may have been useful at 
the analysis stage. 
 
Although we had a high response rate for our expert panel, especially for round 3 where 9 of 
the 11 experts responded, this was not mirrored with our practitioner panel, which is 
another limitation that we encountered. The high response rate from the expert panel is 
perhaps due to the fact it was a smaller cohort and the experts were likely to be more 
engaged and motivated to participate in the process, as opposed to the practitioners who 
were selected at random. 
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The results from our study are important, as it shows this bundle development process has 
been robust, with broad stakeholder involvement from a large number of countries. The 
practitioners involved had recent practical experience and a deep knowledge of the realities 
of practicing in their setting. The use of an expert panel also allowed us to triangulate the 
views of the practitioner panel with those of the experts. It also ensured we were up to date 
with recent research and recognised new innovations that practitioners in LMIC may not be 
aware of. 
 
Recommendations 
This study has highlighted the chance to change the way in which maternal sepsis is 
managed in low and lower-middle income countries. Now that this care bundle has been 
developed, we recommend that it should be operationalised in a low-resource setting. 
Various toolkits will need to be developed for its implementation. 
 
A feasibility study to test the usability and practicality of the FAST-M bundle are currently 
underway and was commenced in April 2017 in Malawi. Following this, a large multi-centre 
cluster randomised controlled trial can then be carried out, to assess the efficacy of using 
this bundle in the management of maternal sepsis.  
 
Conclusions 
The use of care bundles in sepsis is shown to improve clinical outcomes. Currently, for 
maternal sepsis in low and lower-middle income countries, the use of the available sepsis 
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bundles are inappropriate and not feasible. A clinically relevant and feasible maternal sepsis 
care bundle has been developed by a consensus forming process with a wide range of 
practitioners and experts. This low-income maternal sepsis bundle can be developed into a 
package to be implemented and tested in an appropriate setting in the near future.
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CHAPTER 4: DEVELOPING AN EXPLORATORY THEORY OF CHANGE 
TO IMPLEMENT A MATERNAL SEPSIS CARE BUNDLE IN MALAWI 
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ABSTRACT 
 
Background: 
A theory of change (TOC) is a method used to describe the way in which a programme can 
achieve a specific long-term outcome, through a logical sequence of intermediate 
outcomes144,145. It is in an iterative group process, undertaken through a series of 
workshops. Stakeholders undertake “backwards mapping” to identify the necessary pre-
conditions required to achieve the long-term outcome. A theory of change approach can be 
used for the development and implementation of new complex packages or interventions. 
 
Methods: 
A theory of change development process was undertaken involving multiple workshops, held 
as “in-country” meetings. These were held in various locations in Lilongwe, Malawi over a 
one-week period in May 2016. Stakeholders included doctors, researchers, clinical officers 
and nurse midwives, who offered enthusiastic and compelling ideas. The focus was on the 
newly developed FAST-M bundle for the management of maternal sepsis in low-income 
settings. 
 
In total, 71 people participated in 6 theory of change workshops. Each of the proposed 
bundle elements were discussed in detail, outlining the key barriers and facilitators to its 
implementation, and ideas of how to overcome these. At the end of the weeklong 
programme of workshops, an action plan with the next steps was created, to assist in 
planning for implementation of the bundle.  
96 
 
Conclusions: 
An exploratory theory of change has been developed to support plans for the 
implementation of a low-income maternal sepsis bundle. Plans for a feasibility study to pilot 
the implementation of the bundle in a low-income country setting are underway, and the 
outcomes of this will be used to develop the theory of change further. 
 
 
Keywords: 
maternal sepsis; bundle; theory of change; implementation; intervention development; 
stakeholder involvement 
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INTRODUCTION 
 
A theory of change (TOC) is a planning tool, used mainly in government and not-for-profit 
sectors, to develop solutions to complex social issues146. The development of a theory of 
change is a participatory process147 which involves a group of stakeholders coming together 
to identify a “long term outcome” and then document how and why this goal will be 
reached146.  
 
Undertaking a theory of change can help to show how a programme intends to meet the 
desired outcomes by addressing the problems that may arise148.  It ensures boundaries are 
clarified and enables the team to outline the outcomes that are achievable as well as those 
that are beyond the scope of the programme in question148. Stakeholders can use this 
iterative process to understand and evaluate the underlying logic or rationale of a proposed 
program149. 
 
Stakeholders undertake the process of “backwards mapping”, whereby the long term or 
ultimate outcome is identified first, followed by ascertaining the necessary immediate or 
intermediate outcomes, which are required to meet the long term goal148. This process 
usually culminates in the form of a TOC diagram, which is a graphical representation of the 
pathways, required to achieve the outcomes.  
 
Developing a TOC involves proposing a number of interventions that can bring about the 
long-term goal. Each outcome proposed in the TOC require one or more “indicators” of 
success150. As implementation of the theory of change progresses, data is collected on the 
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indicators to monitor progress and ensure outcomes have been met. Indicators are usually 
measurable, observable and can be used to evaluate the progress and success of the 
TOC146,147 
 
In addition to the outcomes and indicators, a TOC requires “assumptions”. These are 
conditions which the group recognise need to be in place in order for the outcomes to be 
met145,150.Throughout the TOC process, stakeholders must also explain the “rationales” for 
why the outcomes proposed are necessary preconditions to the long term outcome147. 
 
The long-term outcome is a realistic goal, however there is an ultimate goal (also known as 
the “impact”) that can be placed above the long-term goal highlighting the impact of that 
particular theory of change146. A dashed line can be added to the TOC diagram, called the 
“accountability ceiling” which distinguishes it from the long term outcome146. The ultimate 
goal transcends what the group feel they can achieve through their own efforts, therefore 
everything the group feel they can achieve is placed below the accountability ceiling147. 
 
Development of the theory of change usually takes place over a number of meetings or 
workshops, held by a facilitator or group of facilitators. Stakeholders are consulted on their 
opinions throughout the process until a final causal pathway is developed. Taplin et al advise 
that the average number of stakeholders at each meeting should not be less than 6-8 and 
each meeting should last at least 2 hours in length150. There is no limit suggested on the 
number of meetings but to be continued until the outcomes are validated and agreed upon 
by the stakeholders148. 
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Materials required for these workshops include flip charts, post-it notes and coloured pens 
or markers. Stakeholders often write their ideas on separate sheets of papers or notes and 
facilitators then work through them, either in small groups or as a larger group, exploring the 
themes and ideas presented150.  During workshops, team members elicit the barriers and 
facilitators to the implementation of the theory of change and develop tailored outcomes. 
Hailemariam et al identified that one of the most important goals of a TOC workshop is to 
“elicit stakeholder buy-in”151. This is important to ensure stakeholders feel involved from the 
beginning by ensuring they are involved in the development of the final intervention151. 
 
We have recently carried out a global consensus to develop a new care bundle for the initial 
management of maternal sepsis in low-income countries. The bundle consists of five well-
known interventions, that when carried out together, we hope will improve maternal sepsis 
care. The items included within the bundle include: administration of intravenous fluids; 
early administration of intravenous antibiotics; identification and removal of the source of 
the infection; transport to the appropriate location of care and monitoring of the mother 
and neonate. Components of the bundle can be remembered by the acronym, FAST-M. 
 
In this chapter, we demonstrate the use of the theory of change approach explore the 
barriers and facilitators to the implementation of this bundle, through a series of in-country 
workshops held in Lilongwe, Malawi. This framework will help to identify the interventions 
and desired outcomes for a pilot study, and will be followed through by members of the 
University of Birmingham team and our colleagues based in Lilongwe, Malawi. This 
exploratory theory of change can then be evaluated and refined using the pilot study results.  
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METHODS 
Setting & Background Work 
Development of this TOC took place through workshops and meetings held in Lilongwe, the 
capital city of Malawi. The University of Birmingham Medical School and College of Medicine 
in Malawi work together frequently on global maternal health projects, with academic 
clinicians regularly carrying out research projects at facilities in both Blantyre and Lilongwe.  
 
Once the Delphi study was completed and the maternal sepsis bundle for low-income 
countries was developed, we decided to organise meetings with stakeholders in Lilongwe to 
understand the needs and requirements of healthcare workers in the area and discuss how 
to successfully implement this bundle, using a theory of change approach. 
 
Lilongwe was chosen as the destination as it is the capital city of Malawi and therefore more 
accessible for clinicians and researchers to reach for the meetings. Three months before the 
meeting, we sent invitations out to notable researchers, doctors, clinical officers, nurse-
midwives and technicians in Malawi inviting them to take part in a weeklong programme to 
discuss the new bundle. A “welcome pack” with information on the project so far and 
relevant important papers and reports was also forwarded to stakeholders two weeks prior 
to the meeting, so that they were well informed about the project thus far. Many 
stakeholders had already taken part in the Delphi study and were aware of the plans to 
develop and implement this low-income maternal sepsis bundle. 
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In addition to our own work on developing the sepsis bundle, other members of our 
research team had recently undertaken a data collection project in Blantyre, Malawi to 
establish resource availability for the management of maternal sepsis in the region. 
Information from this cross-sectional study was also useful to highlight the difficulties 
healthcare workers in Malawi face when managing patients with maternal sepsis and the 
resources already available to them. 
 
In total, six theory of change workshops took place. Three were formal workshops with a 
variety of delegates with a background or interest in maternal sepsis. The remaining three 
workshops were site visits, to health centres and hospitals in the region, to discuss pertinent 
questions with healthcare workers working there. 
 
Site Visits 
The first site visit took place at Dzaleka Health Centre and Refugee Camp. Five clinical 
researchers from the University of Birmingham met with a clinician, two nurse-midwives and 
administrator. We asked questions in order to better understand the resources available to 
the staff in this health centre and the region that they cover. We discussed the barriers to 
providing safe and efficient care for women presenting with signs of sepsis and how we may 
overcome them. The new sepsis bundle was introduced and we were able to discuss how 
this might be introduced and some useful tools that would help with its implementation. 
 
The same day, we arranged a larger stakeholder site visit at Dowa District Hospital. Here, we 
met with the District Nursing Officer (DNO) in addition to 13 clinical officers, nurse-midwives 
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and technicians/assistants. The workshop began with members introducing themselves and 
describing their background. Although all stakeholders could speak English, one of the nurse-
midwives volunteered to translate from English to Chichewa (Malawi’s national language), in 
order to ensure all stakeholders could follow the meeting. 
 
We began by introducing the bundle, outlining its purpose and plans for its implementation. 
Each of the five components of FAST-M were discussed in detail. We covered the issues 
healthcare workers in the hospital face regarding sepsis management and what was 
available in terms of resources and current practice. The main concerns were identified and 
ideas for solutions to these were offered. The session, which lasted just over an hour 
concluded with ideas for implementation of the bundle, including helpful resources such as 
monitoring tools and training sessions. 
 
The final site visit took place at Mitundu Hospital, located further out in the Lilongwe district. 
This community hospital is a referral centre for 15 health centres with 60, 000 patients 
within its catchment area. We met with the clinical officer and nurse-midwife in charge to 
get an introduction to the facilities and challenges they face on a daily basis. As with the 
other site visits, we introduced the newly formed FAST-M bundle and identified how we can 
implement this in sites such as Mitundu Hospital, within Malawi. It was important to again 
discuss the implementation tools, which would be useful including posters, pocket cards and 
leaflets. The main barriers to sepsis management were discussed fully and solutions to these 
issues were suggested. 
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TOC Workshops  
The first formal TOC workshop was held on the third day of the trip. This was the first of 
three days of workshops to discuss the implementation of the FAST-M bundle. All three 
workshops were held at Kamuzu College of Nursing in Lilongwe. In preparation, in addition 
to the delegate packs created, materials such as notebooks, pens and markers were 
available for note taking. Large sheets of white paper that could be stuck to walls were used 
as temporary whiteboards, which proved useful during group work. 
 
As for other TOC meetings, individual members introduced themselves and their 
backgrounds. Doctors, nurse-midwives and clinical officers were in attendance, along with 
research and administration staff. 
 
In addition to the five clinical researchers from the University of Birmingham, there were 
representatives from a number of organisations. This included two clinical officers who 
represented the Malawi Association of Obstetric Clinical Officers (MAOCO) as well as 
delegates from a variety of charities and NGO’s such as: Save the Children, PACHI (Parent 
and Child Health Initiative) and JHPIEGO (Johns Hopkins Program for International Education 
in Gynecology and Obstetrics). There were also representatives from the Malawi College of 
Medicine and Kamuzu College of Nursing as well as the Reproductive Health Unit (RHU) of 
the Republic of Malawi’s Ministry of Health. We were grateful to be also joined by the Chief 
Executive of the UK Sepsis Trust and Chief Executive Officer of the Global Sepsis Alliance 
(GSA), who is a critical care doctor in the UK. His successful work in developing the “Sepsis 
Six” bundle in the UK gave an interesting and relevant perspective. In total, there were 18 
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delegates on the first day of the workshops, followed by 14 on the second day and 12 on the 
final day. 
 
We began by introducing our project and proposing our long-term goal: to improve the 
initial management of patients with maternal sepsis in low and lower-middle income 
countries. An interactive PowerPoint presentation was given on the background of the 
project and the work done thus far, including information on our meetings with the World 
Health Organization (WHO) and possible collaboration. This first meeting consisted of a full-
day programme with group discussions in the morning and smaller breakout group sessions 
in the afternoon, followed by a plenary session.  
 
The morning session covered the main issues and challenges in delivering high quality sepsis 
care to pregnant and postpartum women. As a group, we discussed our long-term goal and 
discussed how feasible and realistic this is. Delegates were seated around a large square 
table so that discussions could be had comfortably within the group. Information was given 
on the current practice and guidelines and the role of the government and Ministry of 
Health, which helped us to understand how implementation of this bundle may be 
streamlined. 
 
We then split into three main groups. Each group discussed two bundle elements as well as 
how to recognise maternal sepsis, by use of a trigger (a project currently underway by the 
WHO maternal sepsis team). The three groups covered the following: Fluids & Transport, 
Monitoring & Trigger and Antibiotics & Source Control. Delegates were assigned an hour to 
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discuss what was needed to make the bundle successful in these areas, thinking about the 
people, equipment and communication requirements in addition to systems management 
and teamwork. Delegates were also asked to consider the social, political and legal issues 
and to identify barriers to implementation of the bundle and solutions to these.  
 
The small groups then presented to the rest of the group and opinions were invited from 
other members, throughout the session. Delegates were enthusiastic and presented very 
well rounded and thought out ideas. Resources used during this process included the 
temporary whiteboards, markers and notepads/pens. 
 
The plenary session for this day used post-it notes to allow delegates to come up with 
individual ideas, which could then be grouped together. During this part of the workshop, 
delegates were asked how FAST-M could be made so easy that everyone would use it, as 
well as finding out what information healthcare professionals would want to know about its 
use. This session culminated in a visual representation of the ideas presented in the form of 
a post-it note histogram. The short-term outcomes required to achieve our long-term goal 
were also suggested.  
 
During the second workshop day, we focussed on the implementation plans including the 
possibility of a pilot study to assess the feasibility of the FAST-M bundle, and its 
implementation within the Malawian Healthcare System. Information was gained on the 
design and outcomes for the study in addition to suggestions of possible pilot sites within 
Lilongwe and the surrounding areas. 
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The final workshop centred on tools that could be used for the bundle implementation 
process, for triage in a hospital and health centre setting. Examples of tools, pathways and 
bundles already in use in the Malawian healthcare system were reviewed and this was useful 
in identifying what could work in the region. Preliminary designs for a FAST-M proforma 
were undertaken and plans for the pilot study were discussed again in detail. An action plan 
with the important post-workshop plans was created and will be followed up by members of 
both the University of Birmingham team and colleagues based in Malawi. 
 
Data Collection 
Data was collected through scribing in detail each of the discussions, in addition to recording 
the information from the post-it notes & whiteboard collection. No personal information 
was obtained from participants and no formal ethical clearance was required. Stakeholders 
gave informed consent to participate prior to the meeting, upon accepting the invitation to 
attend. 
 
Post-Meetings Work 
Following the workshops, minutes from the meetings were used to create an executive 
summary report, which was sent to all delegates in addition to ministry officials and other 
relevant personnel (see appendix 5).  Work began on developing the exploratory theory of 
change diagram and the information obtained from the workshops was used to identify the 
important outcomes as well as the facilitators and barriers to its implementation. 
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RESULTS 
 
A final theory of change (TOC) diagram has been developed through six theory of change 
workshops held in Lilongwe, Malawi. This TOC diagram shows the pathway and interventions 
required to achieving the overall long-term goal and highlights the important barriers and 
facilitators to implementing the FAST-M bundle.  
 
Outcome Pathway 
Figure 21 shows the preliminary exploratory theory of change diagram. The long-term 
outcome is highlighted as “Improved initial management of maternal sepsis” followed by the 
impact, which is to “decrease maternal mortality". In order to achieve this long-term goal, 
there are outcomes to be achieved in various sectors relating to the use of the FAST-M 
bundle. The diagram highlights the individual objectives for each part of the bundle (Fluids, 
Antibiotics, Source Control, Treatment and Monitoring) under the sub-headings of Physical 
Resources, Human Resources, Educational Resources and Behavioural Resources. Identifying 
the individual needs and objectives in this way allows us to establish the short-term goals 
required to meet the long-term outcome. 
 
Below the flowchart, is an arrow outlining the key assumptions over the course of the 
model. These are conditions or resources that already exist or are expected to be in place in 
order to carry out the theory of change successfully147,152. These are different to the 
outcomes, which represent interventions or conditions that do not already exist and need to 
be brought about with the aid of the TOC150.  
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F Crystalloid fluids are readily available Staff are available to prescribe and administer fluids
Staff are trained to 
understand fluids should 
be adminstered within the 
first hour of diagnosis
Good communication 
between the prescriber 
and healthcare worker 
administering the fluids
The patient receives IV 
fluids within one hour of 
diagnosis 
A A range of antibiotics are available according to the source of infection Healthcare workers are available to prescribe and administer antibiotics 
Staff are aware antibiotics 
should be administered 
within the first hour of 
diagnosis
Healthcare workers ensure 
the correct antibiotic is 
prepared, checked and 
administered 
The patient receives the 
appropriate IV antibiotics 
in the first hour of 
diagnosis
S Supplies for diagnostic tests are available Healthcare workers use a work plan to assess the source of infection
Staff are aware of the 
various sources of infection 
and how to diagnose it 
effectively
Healthcare workers are 
motivated to carry out a 
thorough assessment to 
identify the source of 
infection
The source of infection is 
correctly identified
Improved 
immediate 
management 
of maternal 
sepsis
T
There are an adequate 
number of ambulances to 
take patients to and from 
the required location 
Adequate budgeting allows 
staff to ensure fuel and 
vehicles are available
Healthcare workers 
understand when to 
transfer a patient and to 
what facility
Good communication and 
referral process
The patient is transferred 
to the appropriate location 
of care
M
Monitoring equipment is 
available
Equipment is working e.g. 
batteries are available
There are enough 
healthcare workers to 
carry out observations
Staff receive appropriate 
training to carry out 
monitoring and how to act 
on the results
Task shifting takes place to 
support workers
The monitoring of vital 
signs are carried out and 
correctly acted upon 
Decreased 
overall  
maternal 
mortalityPatient-led behaviours e.g. 
to ask for observations are 
encouraged to involve 
ptients in their care and 
reduce burden on staff
Physical 
Resources 
Human 
Resources 
Educational 
Resources 
Behavioural 
Resources 
Overall 
Outcomes 
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Figure 21: Theory of Change Outcomes Pathway Diagram 
  
Key Assumptions 
• Assurance of buy-in and backing from the Malawi Ministry of Health Reproductive Health Unit (RHU) and 
ability to integrate with co-existing projects such as the Safe Motherhood Initiative 
• Adequate funding to be secured to pilot the use of the bundle, appropriate for a multi-centre feasibility study 
in and around Lilongwe, Malawi 
• Engagement of staff at all levels and a willingness to learn new skills and techniques 
• Co-operation of staff to adhere to the bundle guidelines or protocols  
• Staff are given the time and resources to attend training sessions to use the bundle 
• Adequate resources to be available to staff to successfully complete bundle paperwork including printing 
facilities to create work plans, booklets and posters 
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Interventions & Rationales 
Interventions are the action points to be undertaken as part of the theory of change in order to reach the long-term goal and rationales 
are the logic and reasoning behind these interventions147. Some of the main interventions and rationales, which are highlighted on the 
TOC diagram are described in table 10 below, and are grouped as per the sub-categories of the diagram. 
 
Table 10: Interventions and rationales for TOC diagram 
 
Preliminary Outcome 
 
Interventions Rationales 
FLUIDS   
Crystalloid fluids are readily 
available 
Improve communication between facilities and 
hospitals, ensure champions/representatives 
involved 
Regular checks and ensuring individuals 
are responsible for certain items will help 
to prevent stock issues of basic fluids such 
as crystalloids, which are recommended in 
sepsis 
 
Good communication between 
prescriber and person administering 
fluids 
1. Prescriber should follow guidance outlining 
fluid choice and rate of administration. 
Instructions should be relayed to person 
administering fluids. 
 
2. Healthcare workers use FAST-M resource 
booklet and mobile application for additional 
support 
Clear information on how to prescribe 
fluids will ensure fluids they are 
prescribed effectively. Good 
communication will ensure fluids are given 
in a timely manner – within the first hour 
of diagnosis 
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ANTIBIOTICS   
Healthcare workers are available to 
prescribed and administer 
antibiotics 
1. Healthcare workers receive training and 
practice skills in onsite training simulations 
and drills 
 
 
2. Healthcare workers use FAST-M resource 
booklet and mobile application for additional 
support 
 
Training will improve healthcare workers 
confidence in managing cases and 
knowing which antibiotics to prescribe for 
different patients 
A range of antibiotics are available, 
according to the source of infection 
Improve communication between facilities and 
hospitals, ensure champions/representatives 
involved 
 
Regular checks and ensuring individuals 
are responsible for certain items will help 
to prevent stock issues and ensure 
different antibiotics are available 
SOURCE CONTROL   
Supplies for diagnostic tests are 
available 
Improve communication between facilities and 
hospitals, ensure champions/representatives 
involved 
Ensuring regular checks and having 
specific job roles will ensure supplies can 
be ordered in time and improve stock 
issues 
 
Healthcare workers are motivated 
to carry out thorough assessment of 
patient to identify the source of 
infection 
 
1. Work plan will contain visual checkpoints for 
sources of infection (on a human figure), 
which can help healthcare workers to 
remember to carry out thorough history, 
examination and diagnostic tests. Checklists 
can also be used 
 
2. Healthcare workers use FAST-M resource 
booklet and mobile application for additional 
support 
Posters and flowcharts have been shown 
to help clinicians and nurses remember 
important points in terms of diagnosis and 
management plans 
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TRANSPORT   
There are an adequate number of 
ambulances to take patients to and 
from the required location  
 
Maintain involvement of broader stakeholders 
(e.g. ministry) and NGO's to ensure ambulance 
numbers present 
 
To ensure ministry and other officials 
aware of problems relating to ambulance 
issues 
Good communication and referral 
process 
 
Healthcare workers use a template referral form 
or tool to ensure every referral follows the same 
format. They can receive feedback for doing this 
correctly which will encourage them to do it more 
often 
 
This will ensure important information 
such as observations, treatment given and 
treatment to be received is given and 
ensure safe transfer of care 
Adequate budgeting allows staff to 
ensure fuel and vehicles are 
available 
 
Maintain involvement of broader stakeholders 
(e.g. ministry) and ensure local champions 
involved to oversee fuel issues 
Individuals taking responsibility will 
ensure issues with fuel supply are 
identified and dealt with early 
MONITORING   
Equipment is working e.g. batteries 
are available  
Audits to check stock, or assign an individual to 
ensure stock checked. Local champions to ensure 
concerns with equipment are highlighted early 
 
Highlighting concerns with equipment 
early can help to ensure working 
equipment is available and monitoring of 
patients can be more streamlined 
 
Monitoring equipment is available Assign individual is responsible for keeping track 
of equipment location or giving it a permanent 
location e.g. attached to a wall 
Keeping equipment in one location or 
ensuring it is returned to its location will 
help to prevent equipment going missing 
 
There are enough healthcare 
workers to carry out observations 
 
Task-shifting should be considered here, so that 
observations can be carried out by support 
workers such as patient attendants instead of 
nurse-midwives 
Task shifting can help to shift the burden 
of observations to non-trained staff so 
that nurse-midwives and other technicians 
can complete other jobs. Patient 
attendants can use tools to ensure they 
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escalate to nurse-midwives and clinicians 
at the appropriate time 
 
Staff receive appropriate training to 
carry out monitoring and how to act 
on the results 
 
1. Healthcare workers follow guidance from a 
care pathway and screening tool e.g. trigger 
tool or MEOWS chart 
 
 
 
2. Healthcare workers use the FAST-M resource 
booklet and/or mobile application to follow 
guidance on how to act on certain 
observations and escalate care 
The screening tool will allow healthcare 
workers to recognise which patients 
require observations. The tool will alert 
healthcare workers to how often 
observations need to be completed and 
when to escalate further 
 
Using the applications will ensure 
healthcare workers are reminded of how 
to act on observations and escalate 
appropriately 
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DISCUSSION 
 
The development of a theory of change can help to plan the implementation of a complex 
intervention in challenging situations. There have been recent examples of the TOC 
approach being used in healthcare, and specifically in a low-income country setting. 
Hailemariam et al explored the use of a theory of change approach to develop a mental 
health care plan in a low-resource setting151. They describe the use of a TOC to support the 
implementation of a new care plan that is designed to help tackle this challenging issue of 
care for mental health patients in rural areas of low-income countries such as Ethiopia151. 
They successfully engaged with local stakeholders and used the TOC approach, which they 
felt was a strong component in the development of the new mental health care plan. They 
found that the process helped to elicit stakeholder buy-in to the project and reduce 
uncertainties about its implementation. Hailemariam et al suggest a TOC approach can be 
used to plan for many different complex health interventions in low-resource settings151. 
 
Main Findings 
The theory of change is considered both a process and a product153 and has been used in this 
instance to evaluate the implementation of the FAST-M low-income maternal sepsis bundle. 
Our project took place in Lilongwe, Malawi over a one-week period with input from a variety 
of respected stakeholders. An exploratory theory of change diagram has been produced and 
a number of short-term outcomes that should be met were highlighted, in order to use the 
FAST-M maternal sepsis bundle and reach the long-term goal of “Improved initial 
management of maternal sepsis in low and lower-middle income countries”. Key 
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assumptions were identified for the successful use of the TOC and it is recognised that 
organisational change, with the help of an implementation committee, should take place in 
order to assist in the implementation of the bundle. 
 
Strengths & Limitations 
There are many strengths to using an exploratory theory of change approach in the 
development and implementation of a new healthcare intervention, specifically for use in 
another country. The experience of holding the workshops in the country where the bundle 
is intended to be used, allowed us to understand how maternal sepsis care is practiced 
currently in Malawi and the challenges that they face on a day-to-day basis. We were able to 
understand what interventions have been successfully used in Malawi and hear from 
healthcare workers “on the ground” who deal with cases of maternal sepsis daily. The fact 
that we were able to hear from such a diverse group of stakeholders was another advantage 
of our theory of change process. This included ministry and government officials as well as 
NGO representatives who were able to give us insight into the difficulties of the Malawian 
healthcare system and the resources that are available. In addition, nurses and clinicians 
working in the health centres and hospitals, who diagnose and treat patients everyday, were 
able to give us a valuable insight. 
 
Using this TOC approach, we were able to plan an intervention with strong involvement from 
an engaged community base. Involvement of the community has been shown to ensure 
sustainability of the outcomes presented151. It is also an effective method to engage with 
and obtain buy-in from multiple stakeholders145. This approach has also enabled us to 
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highlight the barriers to implementation of the bundle and develop strategies, with those 
involved, on how to overcome these. 
 
It is recommended that a TOC can be used to pilot the feasibility of an intervention154. Using 
a TOC in this way can help to identify any gaps in the knowledge and alert the team to any 
research questions that need to be further addressed during the pilot study stage. 
Therefore, the TOC can be used as a guide when planning the feasibility study for the bundle 
and can be further adapted and improved throughout the process, using feedback from the 
study as a guide. 
 
However, there are some limitations to using a TOC approach. Although the TOC can be used 
to guide feasibility, it is not practical to assess the challenges that may be faced throughout 
the implementation process and due to the nature of TOC development, all assumptions and 
interventions are suggested at the beginning of the process. It is natural therefore for the 
TOC to be altered and adapted as described above. 
 
Also, due to the backwards-mapping nature of the development process, often there may be 
too many outcomes or complex interventions suggested which could be difficult to achieve. 
It is important to ensure the outcomes are simple, smart, realistic and achievable by those 
involved.  
 
Although we had a wide variety of stakeholders included within our TOC development 
process and had experiences from doctors from both the UK and Malawi in Obstetrics and 
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Critical Care, we were missing input from other specialties including microbiology and 
infectious diseases. Unfortunately, the doctors contacted in both UK and Malawi were 
unavailable to attend, however offered their services and were happy to be contacted with 
queries throughout the TOC process. Involvement of practitioners from these specialities 
may have highlighted some other issues including the local guidance for antibiotics and 
microbiology resistance patterns, which may have proved useful in the TOC planning 
process. 
 
Conclusions 
Through a series of TOC workshops held in Lilongwe, Malawi, we have created an 
exploratory theory of change diagram to support the implementation of the low-income 
maternal sepsis bundle, FAST-M. We recommend the use of this TOC to guide and design an 
appropriate feasibility study that may be used to pilot the new bundle in a low-income 
country setting, such as Malawi, in the near future. The evidence base gained from the 
results from the feasibility study will be then used to refine and formally develop the theory 
of change, with involvement of the key stakeholders in the final development process. 
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CHAPTER 5: DISCUSSION 
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SUMMARY 
The objective of this thesis, as set out in chapter 1, was to develop a new care bundle, which 
can be used in the initial management of maternal sepsis, in low and lower-middle income 
countries. This has been accomplished through an international Delphi method, which 
achieved consensus on the most important and feasible items to be included in the low-
income maternal sepsis bundle, leading to the development of the FAST-M maternal sepsis 
bundle. 
 
In addition, we have undertaken a systematic review and meta-analysis on the use of 
general care bundles in low and lower-middle income countries, establishing a background 
on the efficacy of bundle use in these countries. Finally, following production of the bundle, 
an exploratory theory of change framework has been created following in-country meetings 
held in Malawi, to help facilitate the implementation of the bundle.  
 
In this chapter, the main findings of the thesis will be summarised, followed by the 
recommendations for clinical practice and implications for future research. 
 
Care Bundles in Low Resource Settings 
The question we aimed to answer with this systematic review and meta-analysis was 
whether the use of care bundles, in a variety of settings, in low and lower-middle income 
countries (LMIC), improved the care patients received overall. Additional outcomes included 
a reduction in the incidence of infection and reduced mortality. The studies selected 
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included only adult patients in LMIC and compared the use of bundled care to usual care. 
Both randomised and non-randomised controlled studies were selected and the care 
bundles varied from general sepsis bundles to specific bundles for ventilator-associated 
pneumonia (VAP) and others. Of the ten studies included, five were included in a meta-
analysis for incidence of infection. There was an overall significant reduction in the incidence 
of infection with bundled care (rate ratio 0.58, 95% confidence interval 0.48 to 0.70, 
p<0.001).  
 
Further results were displayed as forest plots without summary measures and could not be 
meta-analysed due to variations in study design. However, from the figures (3 and 4 
respectively), it is suggested that bundled care was not associated with a decrease in the risk 
of mortality or a reduction in severity score (APACHE II).  
 
These results show that care bundles can significantly reduce the incidence of infection in 
LMIC, compared to usual care. However, only ten studies were included in this review and 
further research with a larger number of studies, from similar study designs would need to 
be included in a meta-analysis in order to ascertain if the use of care bundles can 
significantly reduce mortality. Given the findings of this systematic review and meta-analysis, 
the development of a care bundle created specifically for use in LMIC could help to improve 
the care these patients receive and improve the management of conditions such as sepsis. It 
highlights the need for further research into improving sepsis care in these countries and the 
development of further tools including an LMIC specific bundle, to help health professionals 
recognise the importance of managing sepsis early. 
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International Delphi Consensus 
In this chapter, our main aim was to develop a consensus based care bundle for use in the 
initial management of maternal sepsis in low and lower-middle income countries (LMIC). 
This was done using a three stage iterative Delphi method. Following a detailed literature 
review, a comprehensive long-list of items was created for inclusion within the bundle. 
Advice was sought from an advisory panel of experts prior to the final selection of bundle 
items. 
 
For the first round of the Delphi, an online questionnaire was made and sent to healthcare 
professionals working in LMIC. Participants were asked to rank each treatment and 
monitoring item on both importance as well as feasibility (in a health centre and hospital 
setting). For the second round, the same questionnaire was sent to a panel of selected 
international experts in the field. The final round of the Delphi involved feeding back the 
results from the first two rounds to all participants, to identify if consensus had been 
reached. Over 150 participants from 34 countries in total took part. Consensus was achieved 
at the end of round 2 and confirmed in round 3. The final items selected were:  
 Administration of IV fluids 
 Administration of IV Antibiotics 
 Identification and removal of the source of the infection 
 Transport to the appropriate higher-level care facility 
 Monitoring for both mother and baby  
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These final elements were subsequently summarised with the acronym FAST-M to assist 
practitioner recall. Following the development of this robust, evidence-based low-income 
maternal sepsis bundle, the next phase would be to pilot this bundle in a feasibility study in a 
low or lower-middle income country. Based on the results of this pilot study, a multi-centre 
randomised controlled trial can then be undertaken to assess the efficacy of using this 
bundle in the management of maternal sepsis. If successful, this could change the face of 
maternal sepsis management in low-income countries, and help to provide a unique and 
easy-to-follow framework for healthcare professionals, allowing them to recognise and 
initiate sepsis management earlier. 
 
Looking at the literature, there are very few sepsis care bundles that have been created 
specifically for use in LMIC. One example is the bundle created by Dünser et al in 2012, who 
developed an “acute” and “post-acute” bundle for use in both children and adults presenting 
with sepsis in resource-limited settings16. The authors carried out a thorough literature 
review and found that the evidence for the management of sepsis in low-resource settings 
was lacking16. As a group, they therefore identified which of the interventions would be the 
most useful in a low-income sepsis bundle. Members of the Global Intensive Care working 
group of the European Society of Intensive Care Medicine and the World Federation of 
Peadiatric Intensive and Critical Care Societies voted on the interventions presented, at an 
international meeting in 2012. Their findings resulted in two bundles to be created, one in 
the immediate management of sepsis “acute care bundle” and one for the ongoing 
management of sepsis “post-acute care bundle”. The acute care bundle consists of oxygen 
therapy, fluid resuscitation, early and adequate antimicrobial therapy and surgical source 
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control. The post-acute care bundle includes: re-evaluation of antimicrobial therapy, deep 
venous thrombosis prophylaxis, glucose control and weaning of invasive support. The 
authors suggested implementation of these guidelines in a number of ways including 
audit/feedback. 
 
The FAST-M bundle is similar to Dünser’s acute care bundle in a number of ways. Antibiotics, 
fluids and source control are noted in both bundles. However the FAST-M bundle does not 
recommend routine oxygen therapy and Dünser’s bundle does not discuss transport to the 
appropriate location and distinct monitoring. From our Delphi study, oxygen was deemed as 
less important than other treatment items by both panels. Only 32.9% of practitioners gave 
oxygen therapy a maximum score for importance of 5/5 (see figure 9) and only 9.1% of our 
expert panel gave it a score of 5/5 (see figure 17). On the scatter plot diagram for both 
practitioners and experts, it is ranked fairly low when plotted among other treatment items 
in terms of feasibility (as shown in figures 15 & 19). This shows that our stakeholders do not 
necessarily think oxygen is a core item required for the low-income maternal sepsis bundle. 
This could be for a number of reasons including lack of resources or monitoring of oxygen 
saturations.  
 
This preliminary FAST-M bundle has been created with the intention of assisting healthcare 
workers in the initial management of maternal sepsis in low and lower-middle income 
countries. Following an initial pilot study, any amendments or improvements can be made to 
the bundle, as necessary in order to take it further and allow its implementation into 
national guidelines. 
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Exploratory Theory of Change 
A theory of change is often used to help facilitate the implementation of complex healthcare 
interventions. Chapter 4 describes the process of the development of a theory of change, for 
use in the implementation of the FAST-M low-income maternal sepsis bundle. 
 
Through a series of in-country meetings which took place in Lilongwe, Malawi in May 2016, 
we heard from a number of local, national and international stakeholders and discussed the 
bundle, in addition to how best to implement it in a low-income country setting. Through 
group discussions, an exploratory theory of change diagram has been produced outlining the 
short-term outcomes to be achieved, categorised by the different parts of the bundle. 
During the implementation process, meeting these short-term outcomes will help to achieve 
the long-term goal of “Improved initial management of maternal sepsis in low and lower-
middle income countries”.  
 
From the in-country meetings, we were better able to understand the needs of healthcare 
workers in low-income countries such as Malawi. The important information gained will 
allow us to plan the implementation of the bundle for the feasibility study including the 
resources and tools required to ease the implementation process. Following the proposed 
feasibility study, the theory of change can be formally developed and improved, in order to 
be used for the next stage of operationalisation and implementation. 
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RECOMMENDATIONS & IMPLICATIONS FOR FUTURE RESEARCH 
The new low-income maternal sepsis bundle is a valuable development in maternal sepsis 
research and if successful, could help to improve sepsis care that women receive in LMIC. As 
mentioned previously, the ultimate aim is to trial the FAST-M bundle in a multi-country 
cluster randomised controlled trial. However, prior to this, a feasibility study should be 
undertaken in low-income country to pilot the bundle. Currently, the University of 
Birmingham team are working with the corresponding team in Malawi to undertake a 
feasibility study in a number of healthcare centres and hospitals in the Lilongwe region. 
Results from this study will prove to be especially useful in assessing the efficacy of the use 
of the FAST-M bundle in the initial management of women with maternal sepsis in Malawi 
and form the basis of future trials.  
 
This project has also enabled our team to work with the World Health Organization, who 
have supported the work we have undertaken to develop the FAST-M bundle. As a result, 
members of our team have attended global sepsis workforce meetings to discuss the future 
of maternal sepsis care in low-resource settings and this has enabled the team to collaborate 
with them on their recently developed new definitions of maternal sepsis. The on-going 
collaborative work with the WHO & Jhpiego’s “Global Maternal and Neonatal Sepsis 
Initiative” will allow us to continue the advances in the maternal sepsis research field and 
hopefully improve the management of maternal sepsis, focussing on this important cause of 
maternal and neonatal mortality worldwide. 
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APPENDIX 1: SYSTEMATIC REVIEW SEARCH STRATEGY 
 
 
 
((("south america"[MeSH Terms] OR "central america"[MeSH Terms]) OR "latin 
america"[MeSH Terms]) OR "indian ocean islands"[MeSH Terms]) OR "indonesia"[MeSH 
Terms]) OR "pacific islands"[MeSH Terms]) OR "philippines"[MeSH Terms]) OR "middle 
east"[MeSH Terms]) OR "africa"[MeSH Terms]) OR "asia"[MeSH Terms]) OR "developing 
countries"[MeSH Terms]) OR "europe, eastern"[MeSH Terms]) OR ("georgia"[MeSH Terms] 
OR "georgia (republic)"[MeSH Terms])) OR (low income countries[Title/Abstract] OR low 
income country[Title/Abstract])) OR (middle income countries[Title/Abstract] OR middle 
income country[Title/Abstract])) OR (developing countermeasures[Title/Abstract] OR 
developing counterparts[Title/Abstract] OR developing counties[Title/Abstract] OR 
developing countr[Title/Abstract] OR developing countries[Title/Abstract] OR developing 
countries,[Title/Abstract] OR developing country[Title/Abstract])) OR resource-
poor[Title/Abstract]) OR resource-limited[Title/Abstract]) OR africa[Title/Abstract]) OR south 
america[Title/Abstract]) OR middle east[Title/Abstract]) AND ((((((bundle[Title/Abstract] OR 
bundle'[Title/Abstract] OR bundle's[Title/Abstract] OR bundlebranch[Title/Abstract] OR 
bundled[Title/Abstract] OR bundled'[Title/Abstract] OR bundledp[Title/Abstract] OR 
bundleflower[Title/Abstract] OR bundleia[Title/Abstract] OR bundleless[Title/Abstract] OR 
bundlelike[Title/Abstract] OR bundler[Title/Abstract] OR bundlers[Title/Abstract] OR 
bundles[Title/Abstract] OR bundles'[Title/Abstract] OR bundles5[Title/Abstract] OR 
bundlesheath[Title/Abstract] OR bundlesheaths[Title/Abstract] OR 
bundlesmembranes[Title/Abstract] OR bundless[Title/Abstract] OR bundlesto[Title/Abstract] 
OR bundlet[Title/Abstract] OR bundlets[Title/Abstract] OR bundlewere[Title/Abstract]) OR 
care bundle[Title/Abstract]) OR "care package"[Title/Abstract]) OR "quality 
improvement"[Title/Abstract]) OR (multi dimensional approach[Title/Abstract] OR multi 
dimensional approaches[Title/Abstract])) OR (early goal directed therapies[Title/Abstract] 
OR early goal directed therapy[Title/Abstract]))) 
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APPENDIX 2: ADDITIONAL INFORMATION SHEET FOR DELPHI PARTICIPANTS 
 
 
Development of a Care Bundle for the Management of Maternal Sepsis in 
Low-Income Countries  
 
Many thanks for considering taking part in this survey which will contribute to our project in 
developing a care bundle for the management of maternal sepsis in both low and lower-
middle income countries (as defined by the World Bank1).  
 
Sepsis during pregnancy and childbirth is a major cause of maternal mortality globally2. Over 
5 million cases of maternal sepsis occur every year2, with significantly more cases identified 
in low income countries3. Sepsis is usually defined as systemic evidence of infection in the 
presence of an infection4. The signs of maternal sepsis can be different to that of a non-
pregnant patient and often patients can deteriorate rapidly5, therefore it is important for 
clinicians to be aware of the signs of sepsis as well as have a robust method of initially 
managing maternal sepsis in order to reduce mortality rates.  
 
In order to manage sepsis effectively, a number of care bundles have been produced 
including those of the Surviving Sepsis Campaign6 and the “Sepsis Six” care bundle7. The 
implementation of these bundles has been shown to reduce mortality8 by up to 44% and 
improve the overall care given.  
 
However, in low income countries, clinicians have been unable to implement the elements 
of these kinds of sepsis bundle in the initial management of their patients presenting with 
sepsis9. Specialists in these countries see it as unsuitable, given the limited resources 
available10. A maternity specific bundle has also not been widely used in these settings. It is 
important to ensure mothers living in low income countries will have access to timely, 
evidence based, and reliable care; when presenting with signs of sepsis. This can be achieved 
by creating a care bundle specific to the needs of maternal sepsis in low and low-middle 
income countries. A specialised care bundle for the management of maternal sepsis will 
provide an evidence-based framework that can be used to commence treatment promptly 
and safely. This project will address this important global need. Having developed this 
bundle we then plan to robustly test it to see if it does offer a benefit above usual care.  
 
In order to create this bundle, we will be using a modified Delphi method, a consensus 
forming tool that aims to collect and aggregate expert opinion in order to agree on a certain 
action or decision11. This will involve members of the Delphi group completing 
questionnaires or being interviewed in a number of rounds, in order to agree on a 
conclusion. Participants then review a report of results and can further amend or justify their 
responses until a consensus is formed.  
 
We will carry out at least two rounds of the Delphi. The first will be in the form of this short 
on-line survey to determine the importance of different elements in the bundle and how 
feasible their implementation will be. The results from these questionnaires will then be 
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collated and members of an expert panel will be interviewed to provide further insights. The 
second round will include ranking of the interventions according to importance and 
relevance, and adding any relevant comments at this time. If at this point, a consensus has 
been reached regarding the most important elements of the bundle, the Delphi will be 
complete. However, if required, a third round will commence whereby we will ask Delphi 
members to review the list again and provide final input.  
 
We thank you again for taking part; your responses will be invaluable to our research. If you 
have any further questions or would like to find out more, please don’t hesitate to contact 
one of our researchers via email at: .  
 
Kind Regards,  
 
 
University of Birmingham Global Maternal Health Sepsis Team, Birmingham, UK  
 
 
 
 
 
 
 
 
 
 
 
 
1. The World Bank. Country and Lending Groups: Low and Low-middle Income Countries. (Online). 2015. Available 
from: http://data.worldbank.org/about/country-and-lending-groups.  
2. Say, L et al. Global causes of maternal death: a WHO systematic analysis. Lancet Global Health. 2014. 2:e323-333  
3. Van Dillen, L et al. Maternal sepsis: epidemiology, etiology and outcome. Curr Opin Infect Dis. 2012. 23:249-254  
4. United Kingdom Sepsis Trust. Toolkit: AMU Management of Sepsis. (Online). 2014.  
5. Bacterial Sepsis following Pregnancy. Green-top guideline, number 64b. (Royal College of Obstetricians and 
Gynaecologists 2012).  
6. Dellinger RP, Levy MM et al. Surviving sepsis campaign: international guidelines for management of severe sepsis 
and septic shock. Intensive Care Med. 2008. 34:17–60  
7. Daniels R et al. The sepsis six and the severe sepsis resuscitation bundle: a prospective observational cohort 
study. Emerg Med J 2011;28:6 507-512  
8. Damiani et al. Effect of performance Improvement Programs on Compliance with Sepsis Bundles and Mortality: A 
Systematic Review and Meta-Analysis of Observational Studies. PLOS ONE. 2015 May. 10(5) 1-24  
9. Dünser, M et al. Recommendations for sepsis-management in resource-limited settings. Intensive Care Med. 
2012. 38:557–574.  
10. Bataar, O et al. Nationwide survey on resource availability for implementing current sepsis guidelines in Mongolia. 
Bulletin of the World Health Organisation. 88:839-846. (2012)  
11. Durand M, Chantler T. Principles of Social Research. Second Edition. 2014 (Open University Press). P64-65.  
 
144 
 
APPENDIX 3: COPY OF QUESTIONNAIRE USED IN ROUND ONE & TWO OF THE 
DELPHI STUDY 
 
 2. Question 1, 2, 3 & 4 
1. Which country do you mainly work in? 
 
 
 
2.  What is your job title? 
Title 
 
Other: 
 
 
 
3. What setting do you work in? 
 
Setting 
  
Other: 
 
 
 
4. In the last six months, have you managed a patient with maternal sepsis? 
 
 
 
5. In your opinion, how important are the following items in the initial treatment of 
severe maternal sepsis (e.g. to be initiated within 3 hours) in low and low-middle 
income countries? 
 
Please only think about the importance of each item. Feasibility will be asked about 
later in the survey. 
 
Please rate the following: 
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 1 = very 
un-
important 
2 3 4 5 = very 
important 
Administer Intravenous Fluid 
 
     
Obtain venous access 
 
     
Administer antibiotics early 
 
     
Give Oxygen 
 
     
Consider assisted ventilation if required 
 
     
Ensure appropriate positioning of the patient 
 
     
Identify and remove the underlying source of infection 
 
     
Give analgesia 
 
     
Give tetanus toxoid (if exposed to tetanus) 
 
         
Give antipyretics 
 
     
Consider a blood transfusion (if needed) 
 
     
Give low-dose steroids 
 
     
Ensure appropriate location for care (e.g. referral to hospital or 
HDU) 
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6. Do you think any items are currently missing from the previous set of questions? If so, please comment below: 
 
5. Question 7 - Importance (Monitoring) 
 
7. In your opinion, how important are the following in monitoring patients already identified as having severe maternal sepsis 
(within the first 3 hours), in low and low-middle income countries? 
 
Please rate the following: 
  
 1 = very un-
important 
2 3 4 5 = very 
important 
Respiratory Rate & Heart Rate (using watch) 
 
     
Temperature (using thermometer) 
 
     
Blood Pressure(Systolic/Diastolic using sphygmomanometer) 
 
      
Mean Arterial Pressure(using sphygmomanometer and 
calculator) 
 
       
Conscious Level 
 
     
Urine Output (by catheter) 
 
     
Capillary Refill 
 
     
Oxygen Saturation (by pulse oximetry) 
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Blood Glucose 
 
     
Blood Culture (prior to commencing antibiotics) 
 
     
Culture of sample (e.g. lochia/urine/other swab) 
 
     
Microscopy/Gram staining (e.g. Pus or MSU) 
 
     
Haemoglobin 
 
     
Lactate Level 
 
     
C-Reactive Protein 
 
     
White Cell Count 
 
       
Platelets 
 
     
Urea & Electrolytes 
 
      
Clotting 
 
     
PCV, haematocrit 
 
     
Sickling 
 
     
HIV rapid test 
 
     
Malaria testing 
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Radiological Investigations (Chest XR, Abdominal XR or pelvic 
USS) 
 
     
Monitoring and treatment of baby if appropriate 
     
 
 
8. Do you think any items are currently missing from the previous set of questions? If so, please comment below: 
  
 
 
9. How feasible do you think the use of the following will be in a health centre in a low and low-middle income country? 
 
(By a health centre we are considering a health facility which is aiming to provide basic emergency obstetric care. As such this is a 
facility where vaginal deliveries will usually take place, as well as routine antenatal and post-natal care but there is no recourse to 
caesarean section. There may be non-physician clinicians present as well as nurses and midwives; however it is unlikely there will 
be any doctors working at this sort of facility.) 
 
Please rate the following: 
  
 1 = 
definitely 
un-feasible 
2 = un-feasible 3 = feasible 4 = definitely 
feasible 
Administer Intravenous Fluid 
 
    
Obtain venous access 
 
    
Administer antibiotics early 
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Give Oxygen 
 
    
Consider assisted ventilation if required 
 
    
Ensure appropriate positioning of the patient 
 
    
Identify and remove the underlying source of infection 
 
    
Give analgesia 
 
    
Give tetanus toxoid (if exposed to tetanus) 
 
    
Give antipyretic 
 
    
Consider a blood transfusion (if required) 
 
       
Give low-dose steroids 
 
    
Ensure appropriate location for care(e.g. referral to hospital 
or HDU) 
 
    
Respiratory Rate & Heart Rate (using watch) 
 
    
Temperature (using thermometer) 
 
    
Blood Pressure(Systolic/Diastolic using sphygmomanometer) 
 
    
Mean Arterial Pressure(using sphygmomanometer & 
calculator) 
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Conscious Level 
 
    
Urine Output (by catheter) 
 
    
Capillary Refill 
 
    
Oxygen Saturation (by pulse oximetry) 
 
    
Blood Glucose 
 
    
Blood Culture (prior to commencing antibiotics) 
 
     
Culture of sample (e.g. lochia/urine/other swab) 
 
    
Microscopy/Gram staining (e.g. Pus or MSU) 
 
    
Haemoglobin 
 
    
Lactate Level 
 
    
C-Reactive Protein 
 
    
White Cell Count 
 
    
Platelets 
 
    
Urea & Electrolytes 
 
    
Clotting 
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10.  
If you have any additional comments, please provide them below: 
 
 
 
11. How feasible do you think the use of the following will be in a district hospital (or any facility where comprehensive essential 
obstetric care is available) in a low and low-middle income country? 
 
Please rate the following: 
 
 
 
  
PCV, haematocrit 
 
    
Sickling 
 
    
HIV rapid test 
 
    
Malaria testing 
 
    
Radiological Investigations (Chest XR, Abdominal XR or pelvic 
USS) 
 
    
Monitoring and treatment of neonate if appropriate 
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 1= 
definitely 
un-feasible 
2 = un-feasible 3 = feasible 4 = definitely 
feasible 
Administer Intravenous Fluid 
 
    
Obtain venous access 
 
    
Administer antibiotics early 
 
    
Give Oxygen 
 
    
Consider assisted ventilation (if required) 
 
    
Ensure appropriate positioning of the patient 
 
    
Identify and remove theunderlying source of infection 
 
    
Give analgesia 
 
    
Give tetanus toxoid (if exposed to tetanus) 
 
    
Give antipyretic 
 
    
Consider a blood transfusion (if required) 
 
    
Give low-dose steroids 
 
    
Ensure appropriate location for care (e.g. referral to hospital or 
HDU) 
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Respiratory Rate & Heart Rate (using watch) 
 
    
Temperature (using thermometer) 
 
    
Blood Pressure(Systolic/Diastolic using sphygmomanometer) 
 
    
Mean Arterial Pressure(using sphygmomanometer) 
 
    
Conscious Level 
 
    
Urine Output (by catheter) 
 
    
Capillary Refill 
 
    
Oxygen Saturation (by pulse oximetry) 
 
    
Blood Glucose 
 
    
Blood Culture (prior to commencing antibiotics) 
 
    
Culture of sample (e.g. lochia/urine/other swab) 
 
    
Microscopy/Gram staining (e.g. Pus or MSU) 
 
    
Haemoglobin 
 
    
Lactate Level 
 
    
C-Reactive Protein 
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White Cell Count 
 
    
Platelets 
 
    
Urea & Electrolytes 
 
    
Clotting 
 
    
PCV, haematocrit 
 
    
Sickling 
 
    
HIV rapid test 
 
    
Malaria testing 
 
    
Radiological Investigations (Chest XR, Abdominal XR or pelvic 
USS) 
 
    
Monitoring and treatment of neonate if appropriate 
    
 
 
 
    
12. If you have any additional comments, please provide them below: 
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Thank you so much for completing this survey. 
 
This survey will form the first stage of the Delphi process that will help us design the bundle. We would like to contact you again with a 
refined set of questions to reach consensus on the right components of the bundle. 
 
If you are happy to be contacted again please enter your email address below, we will only contact you up to two more times as part of 
this process. 
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APPENDIX 4: COPY OF ROUND THREE QUESTIONNAIRE 
 
Following completion of the first and second rounds of the Delphi, we have arranged the top 
ranking elements in the below tables, applying a rank according to the mean score given for 
the importance for each element, as identified by both panels.  
 
The steering committee have reviewed the responses for both practitioner and expert 
panels and found there was consensus on the five most important treatment elements. 
 
Figure 1: The five most important treatment elements (and mean score) using results from 
both panels 
  
Practitioner Panel Rank Expert Panel 
Antibiotics 
 
Mean = 4.90, SD 0.58 
1 
Antibiotics 
 
Mean = 5.00, SD 0.00 
IV Access* 
 
Mean = 4.83, SD 0.69 
2 
IV Access* 
 
Mean = 5.00, SD 0.00 
IV Fluids 
 
Mean = 4.71, SD 0.76 
3 
IV Fluids 
 
Mean = 4.64, SD 0.48 
Source Control 
 
Mean = 4.56, SD 0.82 
4 
Location 
 
Mean = 4.36, SD 0.34 
Location 
 
Mean = 4.39, SD 0.97 
5 
Source Control 
 
Mean = 4.09, SD 1.16 
 
*IV access will be removed from the final ranking as it is intrinsic to two other top ranked elements (administration of IV 
fluids and IV antibiotics). 
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The steering committee also found there was consensus on the following seven most 
important monitoring elements. 
 
Figure 2: The seven most important monitoring elements (and mean score) using results 
from both panels 
  
Practitioner Panel Rank Expert Panel 
Blood Pressure 
 
Mean = 4.85, SD 0.58 
1 
Respiratory Rate & Heart Rate 
 
Mean = 4.82, SD 0.39 
Respiratory Rate & Heart Rate 
 
Mean = 4.80, SD 0.70 
2 
Conscious Level 
 
Mean = 4.82, SD 0.39 
Urine Output 
 
Mean = 4.73, SD 0.69 
3 
Urine Output 
 
Mean = 4.64, SD 0.48 
Conscious Level 
 
Mean = 4.71, SD 0.71 
4 
Monitoring of Baby 
 
Mean = 4.64, SD 0.48 
Temperature 
 
Mean = 4.65, SD 0.75 
5 
Blood Pressure 
 
Mean = 4.55, SD 0.66 
Monitoring of Baby 
 
Mean = 4.46, SD 0.94 
6 
Temperature 
 
Mean = 4.27, SD 0.96 
Oxygen Saturation** 
 
Mean = 4.38, SD 1.00 
7 
Oxygen Saturation** 
 
Mean = 4.27, SD 0.96 
 
** Oxygen Saturation was ranked highly in terms of importance but many practitioners reported it was not currently 
feasible in their setting. Following discussions at the WHO meeting in February, it was suggested that due to its importance 
this should be included, and recommended for use in those facilities where it was available. 
 
In addition to the tables above, please find below some figures showing further results from 
the first two rounds. 
 
Figure 1 & 2 are scatter plots showing the importance against feasibility scores to show the 
trend for the elements in both hospital and health centre settings from round 1.  
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Figures 3 & 4 are stacked bar charts showing the distribution of scores given in terms of 
importance of each item by our expert panel in round 2. 
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Considering the above information, the key elements that were consistently found to be 
both feasible and important are as follows: 
 
IV Antibiotics 
IV Fluids 
Source (identify source and source control) 
Location (right facility and level of care) 
Monitoring of mother: blood pressure/ respiratory rate/ heart rate/ conscious level/ 
temperature/ urine output/ oxygen saturations (if available) of fetus/neonate 
 
1. Do you agree that the above key elements should be included in the final bundle? 
Please provide comments if you wish. 
  
Treatment Elements 
 
Monitoring Elements 
 
Comments: 
 
2. Are there any treatment or monitoring components you would like to add to the final 
bundle? 
 
 
3. Are there any treatment or monitoring components you would like to remove from 
the final bundle? 
 
 
 
Thank you so much for completing this survey. These results will form the important final 
part of the Delphi process. We will be sure to contact you again soon to update you 
regarding the final results. 
  
161 
 
APPENDIX 5: EXCECUTIVE SUMMARY OF MALAWI MEETING, MAY 2016 
 
 
 
Malawi In-Country Meeting Executive Summary 
Lilongwe, Malawi, 16-20th May 2016 
 
 
 
Background: 
Maternal sepsis is the third most 
common direct cause of maternal 
mortality accounting for 11% of 
maternal mortality worldwide (Say, 
2014). A care bundle can be defined as 
“a small, straightforward set of 
evidence-based practices that, when 
performed collectively and reliably 
improve patient outcomes” (Institute for 
Healthcare Improvement, 2015). In high 
income countries, the introduction of 
care bundles has shown to double 
survival (Barochia, 2012 and Damiani, 
2015). Unfortunately, there are no such 
bundles that are suitable for use in low-
income countries.  
 
As a team, we undertook a robust approach to develop a low-income maternal sepsis bundle 
that can be used in countries such as Malawi. This consisted of a modified Delphi approach, 
which engaged a broad range of LMIC practitioners and an additional international expert 
panel. The 3 rounds of the Delphi involved rating all potential bundle elements for both 
importance and feasibility in a LMIC hospital and health centre setting. This was then 
combined with feedback from in-person meetings of the WHO maternal sepsis working 
group. It was decided, in order to conclude the bundle development process, we would hold 
an in-country workshop meeting in Lilongwe in May 2016 to discuss the final components of 
our FAST-M bundle which consists of timely administration of Fluids, Antibiotics, Source 
Control, Transport and ongoing Monitoring (of mother and fetus/neonate).  And how to 
operationalise and test this bundle. 
 
Objectives of the meeting: 
1. Discuss each of the final components of the bundle and its operationalisation at an 
in-country meeting in Malawi 
2. Discuss and design a pilot study to assess the feasibility of the FAST-M bundle and its 
integration in the Malawian healthcare system 
3. Ascertain potential sites for pilot study by carrying out site visits  
Bundle 
development 
Operationalisation 
Pilot 
studies 
Clinical 
Trial 
January 2017 
12 Months 
36 Months 
Evidence gathering and evaluation 
International consensus of initial 
contents 
Broad team of stakeholders from LIC 
In-country meeting in Malawi 
MOH and grassroots input 
Implementation strategy 
Theory of Change Development 
Pilot sites in Malawi  
Evaluation of clinical outcomes and 
process measures  
Bundle optimisation 
Cluster randomised clinical trial 
Demonstrate clinical and cost 
effectiveness at national scale 
May 2016 
Figure 1: Flowchart diagram showing timeline for low-income maternal 
sepsis bundle project 
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In-Country Meeting: Bundle Summary 
 The in-country workshop was held over three days (18-20th May) at Kamuzu Central 
College of Nursing (KCN) in Lilongwe, Malawi. 
 Key representatives from a number of groups attended, including representatives from 
Malawi Ministry of Health (RHU), KCN, Malawi College of Medicine, Jhpiego Malawi 
Office, Malawi Association of Obstetric Clinical Officers (MAOCO), PACHI (Parent & Child 
Health Initiative), Save the Children, Global Sepsis Alliance/UK Sepsis Trust as well as a 
number of practitioners (nurses/midwives, clinical officers, obstetricians). A full list of 
delegates can be found in appendix 1.  
 Individual meetings were held with representatives from UNICEF, DFID, Dr Charles 
Mwanswambo & the DHO for the Lilongwe region. 
 As a group, agreement was reached on the final components of the FAST-M bundle. 
 Each of the components were discussed in detail, identifying the challenges and 
solutions that will need to be considered. This information will go on to be used to create 
a theory a change, which will be a working model for use in the implementation of the 
bundle. 
 During our discussion, we considered the ways in which we can make FAST-M easy to 
use and identified certain implementation tools that will be useful. This included visual 
aids in the form of cards and posters as well as regular team feedback. It was also 
highlighted that clinical audit and quality improvement would be helpful in allowing the 
healthcare professional to monitor their performance and encourage positive feedback. 
 
In Country Meeting: Pilot Study Design Summary 
 Following discussion of the bundle elements, we considered the proposed pilot study, 
which is planned to take place for 12 months from January 2017. The idea of a feasibility 
study was well received and together, we developed important elements of the protocol 
as below:  
 
 Feasibility Study Aim: To assess the feasibility of the FAST-M bundle and its 
implementation within the Malawian Healthcare System. 
 
 Feasibility Study Objectives: 
o Demonstrate improvement in sepsis care (PRIMARY OBJECTIVE) 
o Gain insight about the delivery/implementation and use of bundle 
o Understand the existing gaps in services 
o User acceptability i.e. how do people like it 
o Identify barriers, strengths and solutions 
o Gather additional costs (e.g. stationary, petrol, instruments, additional staff) 
o Contribute to scaling up the study 
o Explore integration within Malawian Healthcare System 
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 Feasibility Study Outcomes: 
o Strength of Implementation  
o Survey or feedback to assess if people have understood 
o Negative/adverse outcomes e.g. overuse of antibiotics 
o Process outcomes including work on healthcare workers attitudes, knowledge, 
skills and narrative; monitoring adherence and compliance through a checklist. 
o Clinical outcomes including: survival (mortality); neonatal outcome; hospital stay; 
complications and major morbidity 
o Structural outcomes including: numbers of people attending training sessions, 
lack of supplies and human resources 
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Site Visits: 
Site Visits were undertaken at the following heath centres and hospitals: Daeyang Luke 
Hospital, Dzaleka Health Centre, Dowa Hospital and Mitundu Hospital. We held stakeholder 
meetings with clinical officers, nurse midwives and the DHO/DNO. We were able to establish 
the current practice for the management of obstetric patients with sepsis. In addition, we 
identified the barriers to providing care and explored some of the reasons behind these. We 
also introduced the new maternal sepsis bundle, and discussed its implementation. 
 
Action points from the meeting: 
A number of action points were identified upon culmination of the three day workshop, as 
below: 
 
Action Point  Individual(s) Involved 
Develop care pathway screening and action 
tool 
UoB Team to draft and feedback from whole 
team 
Develop onsite training/ skill drill materials UoB Team to draft and feedback from whole 
team 
Develop a FAST-M resource booklet UoB Team to draft and feedback from whole 
team 
Develop visual aids such as posters UoB Team to draft and feedback from whole 
team 
Develop work plan for source control and 
develop visual checkpoints for sources of 
infection (on a human figure) 
UoB Team to draft and feedback from whole 
team 
Develop broad guidance on fluid choice and 
rate of administration 
UoB Team to conduct initial review, send to 
team for consultation, seek national Malawi 
and WHO team endorsement  
Development of a template referral letter 
and standardised feedback system 
UoB Team to draft and feedback from whole 
team 
Develop mobile-based technology to support 
FAST-M including a website/app 
UoB team to explore establishing partnerships 
and funding 
Explore solutions to equipment supply issues 
and maintenance options 
District Health Team and hospital 
administration (discussion with maintenance 
departments) 
Task shifting to patient attendants to carry 
out monitoring roles if locally appropriate 
Ministry of health, District health team and 
ward leadership teams 
Identification of national and local maternal 
sepsis champions 
Ministry of health, District health team and 
ward leadership teams 
Encourage patient led behaviours Ward leadership team 
Explore how to improve/maintain 
communication between facilities and 
hospitals 
Ministry, District health team and ward 
leadership teams 
Maintain involvement of broader 
stakeholders (e.g. ministry and safe 
District health team/Ministry of 
Health/DFID/College of Medicine & 
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motherhood, SRH Nursing/JPIEGO/Save the 
children/UNICEF/MERK for Mothers 
Explore learning about sepsis in pre-clinical 
training curriculum, other training schemes 
and explore FAST-M integration 
College of Medicine/KCN/JPIEGO other NGOs 
Develop dissemination plans for project end UoB, with feedback from whole team 
Develop marketing/ branding material UoB Team + consultancy 
 
Appendix 1:  
Delegate List for Sepsis Bundle In-Country Meeting, Malawi 
 Arri Coomarasamy, University of Birmingham 
 David Lissauer, University of Birmingham 
 Abi Merriel, University of Birmingham  
 Fatima Taki, University of Birmingham 
 Amie Wilson, University of Birmingham 
 Thomson Chirwa, Malawi Association of Obstetric Clinical Officers (MAOCO) 
 Victoria Lwesha, Save the Children 
 Chisale Mhango, Obstetrician from the College of Medicine 
 Edward Scott Mhango, Malawi Association of Obstetric Clinical Officers (MAOCO) 
 Laura Munthali, Nurse Midwife 
 Bejoy Nambiar, Parent and Child Health Initiative (PACHI) 
 Theresa Ngalawesa, Nurse Midwife 
 Violet Manjanja, Nurse Midwife and Lecturer, Kamuzu College of Nursing 
 Tambudzai Rashidi, JHPIEGO 
 Limbika Taizi, JHPIEGO 
 Pilirani Msambati, Reproductive Health Unit, Malawi Ministry of Health 
 Charles Makwenda, Parent and Child Health Initiative (PACHI) 
 Ron Daniels, Global Sepsis Alliance/UK Sepsis Trust 
 
Site Visit List of Delegates, Dowa Hospital, Malawi 
 Arri Coomarasamy, University of Birmingham 
 David Lissauer, University of Birmingham 
 Abi Merriel, University of Birmingham  
 Fatima Taki, University of Birmingham 
 Amie Wilson, University of Birmingham 
 William Banda (NM technician PN ward) 
 Gift Sinoya (CO/nutritionist) 
 Elizabeth K (NM PN ward) 
 David Nkoma (auxiliary nurse PN ward) 
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 Zolane Thom (NM) 
 Lozalia Modiza (NM) 
 Veronica Banda (NM) 
 Pearson Tembo (NM) 
 Themy Temwa 
 Ulemu Chyada 
 Dorothy Imau 
 Chikonde Ntaya (deputy DNO) 
 Blessings Kumundu (nurse supervisor/in-charge) 
 
Site Visit List of Delegates, Mitundu Hospital, Malawi 
 Arri Coomarasamy, University of Birmingham 
 Abi Merriel, University of Birmingham  
 Amie Wilson, University of Birmingham 
 Fatima Taki, University of Birmingham 
 David Lissauer, University of Birmingham 
 Ron Daniels, Global Sepsis Alliance 
 Emmanuel (CO and in-charge) 
 A number of other nurse/midwives/technicians and a ward clerk from the maternity unit 
 
